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Fine particulate matter (PM2.5) has been consistently shown to be associated with all-
cause and cardiorespiratory mortality, such that the United States Environmental Protection 
Agency (EPA) has declared its relationship with mortality to be causal. The EPA also sets 
standards to limit ambient concentrations of PM2.5 nationally and any further changes to these 
standards will require evidence that rigorously demonstrates health benefits. Here, we seek to 
provide information that will directly inform this decision making process. In aim 1 we proposed 
a new method to estimate and visualize trends in the natural history of US all-cause and cause-
specific mortality, 1968-2016. In aim 2, we assessed how intervening to reduce PM2.5 to below 
potential future standards (5 and 10 µg/m3) in all US counties 2000-2016 would have changed 
risk of all-cause and cause-specific mortality, compared to the natural history. These two aims 
were conducted in a synthetic cohort built to represent the exposure and mortality experience of 
the resident US population, using mortality and population data from the National Center of 
Health Statistics. For aim 2, our synthetic cohort was fused to county-specific annual average 
PM2.5 concentrations, which were estimated using EPA monitor data and geospatial modeling. 
We used the generalized computational algorithm formula to estimate risk differences comparing 
the natural history to our two intervention scenarios, accounting for potential confounding by 
county-level socioeconomic variables. In aim 1, we were able to replicate several of the reported 
trends in US mortality since 1968, for example, that life expectancy has increased and 
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cardiovascular mortality risk has decreased. In aim 2, we estimated that risk of all-cause 
mortality by age 80 would unexpectedly increase under both of the stricter PM2.5 standards, 
driven primarily by an increase in risk of non-cardiorespiratory mortality. Cardiovascular 
mortality risk by age 85 decreased under both intervention scenarios. However, our results were 
uninterpretable and likely biased. Even so, our aim 2 analysis provided a new example for how 
one could directly estimate the effect of setting a new nationwide PM2.5 standard on mortality. 
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CHAPTER I: REVIEW OF THE LITERATURE 
 
 
A. Reporting of annual mortality in the United States  
Routine, systematic collection and dissemination of mortality and other vital statistics 
data in the United States (US) was formalized in 1902 with the permanent establishment of the 
Bureau of the Census. In 1946 this work was transferred to the newly created National Office of 
Vital Statistics, under the jurisdiction of the Public Health Service, and in 1960 the National 
Office of Vital Statistics was merged with the National Health Survey to form the National 
Center for Health Statistics, which has responsibility over vital statistics to this day.1 
From the beginning, national mortality in the US has been reported using measures of 
death counts, age-standardized rates, and life expectancy. The use of rates, in particular, makes 
sense given two factors: (1) the type of data generally available on a national level and (2) the 
dynamic nature of human populations. Regarding the former, the total number of deaths in a 
given geographical area (e.g. a county or state) over the course of the year and an estimate of the 
mid-year population size are routinely reported and publically available.2 If one then assumes 
that the size of the population was a linear function of time throughout the year, taking the ratio 
of the death count to the mid-year population count provides a valid estimate of an incidence 
rate.3 The latter prevents investigators from estimating risk of mortality without making further 
assumptions.4 As a result, rates also tend to be the measure of choice for epidemiologic studies 
which examine national mortality as an outcome. 
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In addition to crude rates of mortality, vital statistics are often further stratified by key 
demographic variables, like sex, race, age, or time period. Similarly, all-cause mortality rates are 
given alongside those for specific causes of death.5 These refined measures have allowed for 
comparison of the mortality experience across population subgroups or for investigating how the 
major causes of death have changed over time. Another commonly reported measure is the age-
standardized rate. When reporting only a single measure of mortality, age-standardized rates are 
considered to be more meaningful than crude rates, as they account for the fact that rates of 
mortality are highly age-dependent. If a common age standard is chosen (say the US population 
in 2000), comparison of rates across time in a single population or across multiple populations 
with different age distributions become more straightforward.3 Finally, national vital statistics 
are often used to calculate life expectancy measures, such as life expectancy at birth (the average 
age to which a child born in a given year is expected to live). Unlike the other measures, life 
expectancy calculated using annual age-specific rates of mortality requires assuming 
exchangeability of currently observed data with what that child will experience in the future.3,5 
 
B. Trends in US mortality, 1968-2016 
Between 1968 and 2016, over 108 million Americans died from any cause. During this 
same time period, all-cause, age-standardized mortality rates dropped from 7.5 per 1000 person-
years in 1968 (standardized to the US population in 1940) to 7.3 per 1000 person-years in 2016 
(standardized to the US population in 2010). Life expectancy increased from 69.9 years in 1968 
to 78.7 years in 2016.6-8 The leading causes of death were similar, with slight changes reflecting 
the demographic shift (toward an older population) that occurred over this period. In 1968 the 
top five causes of death were heart disease, cancer, cerebrovascular diseases, accidents, and 
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influenza/pneumonia.7 In 2016 they were heart disease, cancer, accidents, chronic lower 
respiratory diseases, and cerebrovascular diseases.6 In our study the particular causes of interest 
were select cardiovascular causes and all respiratory causes, both of which appear among the top 
five causes of death. While still the top cause of death in the US, age-standardized rates of heart 
disease mortality have dropped dramatically (from 3.64 per 1,000 person-years in 1968 to 1.66 
per 1,000 person-years in 2016, with the same standard populations as above). Conversely, 
mortality due to chronic respiratory diseases has risen over the past few decades.6 
 
C. Overview of fine particulate matter 
 Particulate matter has been classified by the US EPA as one of the six criteria air 
pollutants that pose a threat to human health and the environment. Unlike other criteria 
pollutants, however, particulate matter is a complex mixture of different particles, such as dust, 
sulfur dioxide, organic carbon, elemental carbon, and nitrogen oxides. Usually, this larger 
classification is broken down by the size of the particles. The two main types discussed in the 
literature (also the two types regulated by different EPA standards) are particulate matter with an 
aerodynamic diameter <10 µm (PM10) and particulate matter with an aerodynamic diameter <2.5 
µm (PM2.5). The latter is also referred to as fine particulate matter, with particles between 2.5 and 
10 µm comprising coarse particulate matter (PM10-2.5). Here, we are primarily interested in fine 
particulate matter. 
Components of particulate matter arise from both primary (i.e., emissions) and secondary 
(i.e., reactions in the atmosphere) sources. The major emission sources for PM2.5 are combustion 
of fossil fuels from stationary and mobile sources; these sources also emit other compounds, 
especially sulfur and nitrogen oxides, which then react to become a secondary source of PM2.5. It 
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should also be noted that some components of PM2.5 are naturally occurring, but the EPA has 
estimated that the policy relevant background level (the level that would be observed without 
anthropogenic emissions) for PM2.5 is an annual average concentration of <1 µg/m
3.9 
As required under the 1970 Clean Air Act, the EPA has set and enforces compliance with 
National Ambient Air Quality Standards (NAAQS) for atmospheric levels of the criteria air 
pollutants, including particulate matter. These national standards and the resulting air quality 
regulation programs (e.g. the Acid Rain Control Program, the national motor vehicles emission 
standards, and state-specific implementation plans) are likely the primary driver of the decreases 
seen in ambient concentrations of PM2.5 since nationwide monitoring began in 1999.
10,11  
Every 5 years the EPA assesses whether the NAAQS should be changed, in keeping with 
the Clean Air Act’s statement that the standards should “accurately reflect the latest scientific 
knowledge useful in indicating the kind and extent of identifiable effects on public health or 
welfare which may be expected from the presence of a pollutant in ambient air…”9 This process 
takes into account the policy-relevant scientific literature on the health and welfare effects of the 
air pollutant (compiled in an Integrated Science Assessment), risk assessment analyses, and 
policy considerations. An independent review is then conducted by the Clean Air Scientific 
Advisory Committee (CASAC), which provides a recommendation to the Administer of the 
EPA.9,12 For instance, following a review of the scientific knowledge to date, the EPA lowered 
the primary standard for annual average concentration of PM2.5 in 2012 from 15.0 µg/m
3 to 12.0 
µg/m3. Primary standards are those set for the protection of human health. The secondary 
standard (the standard for the protection of crops, wildlife, climate, etc.) remained at 15.0 µg/m3. 
The 2012 standards further stipulated that the 98th percentile for daily average concentrations of 
PM2.5 should not exceed 35 µg/m
3.13 States that do not meet these standards receive a non-
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attainment designation and must work extensively with the EPA to improve their action plans to 
limit emissions. They can also face economic penalites.14 
 
D. Trends in concentrations of fine particulate matter, 2000-2016 
As shown in Figure 1.1, concentrations of PM2.5 decreased between 2000 and 2016. In 
2000 the median of the monitor-recorded annual average concentrations was 13.07 µg/m3 (IQR: 
10.42, 15.54), while the median in 2016 was 7.66 µg/m3 (IQR: 6.33, 8.70). When comparing 
these trends to the NAAQS values, one can interestingly see that the PM2.5 standard was lowered 
to 12.0 µg/m3 in 2012 despite more than 75% of the monitors detecting concentrations below 
that standard. This indicates that changes to the standard were clearly justified (in terms of the 
balance between the costs and benefits) even when few geographic areas were experiencing 
annual air pollution levels above the proposed standard. 
Examining the trends both geographically and temporally (Figure 1.2), one can see that 
measured PM2.5 concentrations at EPA monitors across the US consistently dropped from 2000 




E. The association between fine particulate matter and mortality 
Particulate matter, as one of the six criteria air pollutants, is monitored and regulated by 
the US EPA. While ambient concentrations have been dropping in recent years,9,10 particulate 
matter remains ubiquitous. Additionally, a large body of evidence from multiple scientific fields 
has established its adverse environmental and health effects.9 Of all the classifications of 
particulate matter, PM2.5 has most consistently been shown to be associated with all-cause 
6 
 
mortality as well as cardiovascular, and respiratory morbidity and mortality following both acute 
(i.e., daily) and long-term (i.e., months to years) exposure.15-26  
Here, we are interested how intervening on annual average PM2.5 would affect trends in 
all-cause, cardiovascular, and respiratory mortality. In the most recent Integrated Science 
Assessment for particulate matter, the EPA declared the relationship between long-term exposure 
to PM2.5 and all-cause mortality to be causal. Estimated relative risks for all-cause mortality per 
10 µg/m3 increment of PM2.5 have ranged between 1 and 1.5, with most being below 1.2.
9 
Research has thus far shown no threshold for exposure to PM2.5 and risk of death,
9 and some 
evidence even suggests that relatively larger decreases in mortality would be observed for 
reductions in already low levels of PM2.5, compared to similar reductions in areas with higher 
concentrations.27,28 It has further been estimated that over 900,000 deaths between 1999 and 
2007 were attributable to annual exposure to ambient PM2.5.
29  
In addition to looking at all-cause mortality, we were also interested in examining cause-
specific mortality. There is good evidence to suggest that long-term exposure to PM2.5 is 
associated with cardiorespiratory (a combined endpoint frequently used in air pollution 
literature) and lung cancer mortality. Given our inability to link data across years, here we focus 
on cardiorespiratory mortality, rather than lung cancer mortality, which likely has a latency 
period which we would not adequately capture. 
 
F. Summary of three important papers on PM2.5 and mortality 
Within the large body of evidence investigating the association between PM2.5 and 
mortality, a few studies deserve particular emphasis. Below, we first summarize two of the early, 
landmark studies that demonstrated in large, prospective cohorts the harmful effects of long-term 
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exposure to PM2.5 on all-cause and cause-specific mortality. In the third paper, we provide a 
more recent example, which highlights current trends toward using causal inference to more 
directly estimate the effects of PM2.5 regulations. This final paper exclusively used massive 
administrative data sets that had been fused to publically available data sources, in a manner 
similar to our own work. 
 
1. The Harvard Six Cities Study 
 The Harvard Six Cities Study19 was a prospective cohort study designed to investigate the 
association between long-term exposure to air pollution (including PM2.5) and mortality. 
Participants were 8111 adults (White and aged 25-74) randomly selected from communities in 
Watertown, MA; Kingston and Harriman, TN; St. Louis, MO; Steubenville, OH; Portage, 
Wyocena, and Pardeeville, WI; and Topeka, KS, who enrolled starting in 1974. This cohort was 
then followed for 14 to 16 years. Daily air pollution concentrations were measured at centrally 
located monitors in each city and averaged within years as well as over the entire study period. 
The investigators used Cox proportional hazards models to assess the association with time to 
death due to any cause and time to death of specific causes, controlling for sex, age, 
current/former smoking status, pack-years of smoking, an indicator of less than high school 
education, body mass index, and occupational exposure. They contrasted exposure 
concentrations in two ways: by creating indicator variables for site and comparing each city’s 
concentration to the overall average concentration and by computing the change in hazard for a 
increase in concentration equal to the difference between the PM2.5 concentration in the most 
polluted city (Steubenville, OH) and the least polluted city (Portage, WI). The authors found, to 
report the main result for the second comparison, that the all-cause mortality hazard in 
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Steubenville was 1.26 (95% CI: 1.08-1.46) times the hazard in Portage. For cardiopulmonary 
mortality (defined as ICD-9 400-440, 485-496), that hazard ratio was 1.37 (95% CI: 1.11, 1.68), 
but the result was null for causes other than cardiopulmonary and lung cancer. The authors 
observed larger all-cause mortality associations among men than among women (sex-specific 
results not reported for cause-specific mortality). 
 The results of Harvard Six Cities Study have been both validated30 and updated for 
extended follow-up.20 The latter analysis added 8 more years of mortality follow-up to the study, 
although PM2.5 concentrations had to be modeled (using data on PM10 concentrations, humidity-
corrected visibility, and season). Over the entire study period (1974-1998), they found an all-
cause mortality hazard ratio of 1.16 (95% CI: 1.07-1.26) and a cardiovascular mortality hazard 
ratio of 1.28 (95% CI: 1.13, 1.44) for a 10 µg/m3 increase in annual average concentrations of 
PM2.5. They also examined respiratory mortality, but, with only 195 events, the results were 
highly imprecise. 
 
2. The American Cancer Society Study 
 The American Cancer Society (ACS) Cancer Prevention Study II was a prospective 
cohort studying mortality in 1.2 million adults (aged at least 30 years and living in a household 
with someone aged 45 or older) living across the US and Puerto Rico. Participants were followed 
from enrollment in fall 1982 until December 31, 1989. The air pollution sub-study drew on data 
from over 500,000 ACS participants, with 295,223 participants included in the PM2.5 analysis.
17 
This latter sample had a mean age of 56.6 years and was predominately White (94.0%). 
Participants’ air pollution exposure was assigned to reflect their exposure level just prior to 
entering the study, based upon the metropolitan area in which they lived (addresses and zip codes 
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were obtained at baseline). For the PM2.5 analysis, the exposure was the median concentration 
over the years 1979-1983 that had previously been calculated by Lipfert et al for 50 metropolitan 
areas using EPA monitoring data.31 
 The authors used Cox Proportional Hazards models to estimate hazards ratios for a 
difference in PM2.5 concentration equal to an increase from the least polluted area (9.0 µg/m
3) to 
the most polluted area (33.5 µg/m3). They controlled for age, gender, race, smoking, body mass 
index, alcohol consumption, less than high school education, and occupational exposure. They 
examined all-cause and cause-specific mortality. Their cause-specific mortality outcome was 
defined as lung cancer mortality (ICD-9 162), cardiopulmonary mortality (ICD-9 401-440, 460-
519), and all other causes of death. For all-cause mortality and cardiopulmonary mortality, the 
estimated hazard ratios were 1.17 (95% CI: 1.09, 1.26) and 1.31 (95% CI: 1.17, 1.46), 
respectively. They observed larger associations in women than in men for cardiopulmonary 
mortality but similar associations for all-cause mortality. 
 
3. Standard non-attainment in the Medicare population 
We now highlight a more recent paper that is among the few published PM2.5 works 
explicitly using the causal inference framework and modern quantitative methods.32 In this study, 
Zigler and colleagues examined the effects of receiving in 2005 a non-attainment designation for 
the 1997 PM2.5 NAAQS on concentrations of PM2.5 in the years 2010-2012 and on rates of 
hospitalization and mortality in 2012. Their analysis sample consisted of approximately 5.5 
million Medicare beneficiaries living in the Eastern United States. The Medicare data were 
linked to PM2.5 data at 829 monitors as well as baseline demographic data from zip codes with 
centroids within 6 miles of those monitors, baseline climate data collected within 150km, and 
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baseline smoking rates from the surrounding county. To be included, the Medicare beneficiaries 
had to live in zip codes with centroids within 6 miles of the monitors, and the authors treated the 
area clustered around an eligible monitor as the unit of analysis. 
To estimate the effect of receiving a non-attainment designation on the areas that 
received such a designation (i.e. the average treatment effect in the treated), the authors used a 
Bayesian approach they had previously developed.33 In short, they used a propensity score 
design, with exposure defined as non-attainment versus attainment of the 1997 standard. They 
further pruned the propensity scores and then matched exposed and non-exposed units by 
breaking up units into 4 groups based on their propensity scores. The authors then used a spatial 
hierarchical regression model to estimate log PM2.5 concentrations that the non-attainment areas 
would have had if they had been attainment areas, including in the model indicators for 
propensity score group and a spatial random effect. The exposure model was run jointly with 
log-linear models for rates of mortality and hospitalization. The final models included a wide 
array of socioeconomic, behavioral, comorbidity, and climate variables as potential baseline 
confounders.  
The authors estimated that the non-attainment designation resulted in a reduction in 2010-
2012 average PM2.5 concentrations of 0.339 µg/m
3 (95% posterior interval: -1.542, 0.668) and an 
absolute reduction in mortality rates of 1.251 deaths/1000 beneficiaries (95% posterior interval: -
2.631, 0.108) within non-attainment areas. Stratified results were not presented. However, they 
interpreted the results cautiously because of the existence of regional measures taken to reduce 
PM2.5 that affected both attainment and non-attainment areas. They further concluded that, for a 
variety of reasons, one cannot use their results to definitively state that the non-attainment 
designation caused the observed decreases in mortality rates. 
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G. Overall state of the literature 
While we have summarized only three important papers above, there is (as we have 
mentioned) a large body of literature examining PM2.5 and mortality. Most of the published 
studies had as their aim the investigation of the shape of an exposure-outcome association, rather 
than the examination of how intervening on particulate matter affects mortality. There are a 
number of striking limitations of the existing literature, which, given their goal of estimating 
internally valid associations in often restricted study samples, may have been justified but in 
light of current directions in air pollution epidemiology (and in epidemiology more broadly) may 
not be justified moving forward. 
With a few, more recently published exceptions,32,34-38 most of the US-based 
epidemiologic studies examining the association between long-term exposure to particulate 
matter and mortality used data from before 2002.11,15,20-22,25,33,39,40 For example, the landmark 
Harvard Six Cities19 and American Cancer Society Cancer Prevention17 studies were conducted 
primarily in the 1980s. Only one study doing extended follow-up in these cohorts used data 
collected after 2000.35 The use of older data in the literature is in part related to the fact that 
nation-wide monitoring of PM2.5 by the EPA did not begin until 1999 (although prior limited 
city-level or study-established monitoring existed).  
Furthermore, many of the populations examined in past studies of particulate matter and 
mortality have been restricted in some way. For instance, prior research has often been 
geographically limited.21,34,36,41,42 Two studies that has used causal inference methods looked 
only at individuals living near monitors in the Western US or just those living near monitors in 
the Eastern US.32,33 This may have been done to study unique, localized events (like the Utah 
Valley steel mill strike or city-level time series analyses), to reduce bias due to spatial 
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confounding, or to investigate research questions within a more geographically limited target 
population. Many studies have also avoided using data from rural counties due to their small 
populations or lack of an EPA monitor. This is despite the growing evidence that further 
reducing PM2.5 levels in areas where levels are already low could have greater benefits than 
similar reductions in regions with higher concentrations.27,28 
Additionally, past epidemiologic studies have generally used simple methods to assign 
PM2.5 exposure, such as applying to each individual the exact value measured at the nearest 
monitor (generally resulting in a restriction to participants living near monitors).43 However, 
such restrictions could be overcome through the use of existing, rigorous geostatistical 
approaches, such as Bayesian Maximum Entropy.44,45 A few studies have successfully applied 
more advanced spatial methods to look at the health effects of particulate matter in a single city21 
or at the state level.46-48 The most geographically spread of these epidemiologic studies looked at 
PM2.5 and brain structure within a small but nationwide subset of the Women’s Health Initiative 
Memory Study.49 However, no PM2.5 epidemiologic study has implemented these methods on as 
wide a scale as the entire contiguous US, although environmental modeling studies have shown 
it is possible.29,43,45,50 
Past PM2.5 research has also often worked within select sub-groups of the US population, 
e.g. senior citizens,22,23,33,51 US veterans,39 individuals with chronic diseases,40,52 or white adult 
residents of select study cities.19,20,35 As above, this is appropriate if one’s target population is 
those select subgroups, as would be the case if one wishes to assess the association within a 
population likely to be highly affected (e.g. the elderly or those with comorbid conditions). 
However, if one’s goal is to look at the effects of national air pollution policies, one would more 
likely have a much broader target population, such as the entire US population. 
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Then, while some recent studies have been less temporally, geographically, or 
demographically restricted, these studies tended to use traditional regression methods.24 While 
these methods have perhaps been sufficient for preliminary work establishing an association 
between PM2.5 and mortality, they are unlikely to directly answer the questions of interest to 
policymakers related to the effectiveness of current air pollution policies as well as benefits to be 
gained from future policies. If examining policies or interventions is the goal, then the causal 
inference framework and related statistical methods currently provide the best approach. To date, 
there has been only limited application of causal inference methods, such as propensity scores 
and instrumental variables,32,33,42 in the PM2.5 epidemiologic literature. No studies apply Robin’s 
generalized computational algorithm formula (g-formula), which can be adapted to estimating a 
wide variety of counterfactual comparisons including comparing outcomes under an intervention 
to the natural history.53 Finally, while many studies have examined the association between 
PM2.5 and cause-specific mortality, none have conducted a formal competing events analysis. 
There is a growing literature, though, on how best to account for competing risks,53-58 and future 
studies examining PM2.5 and cause-specific mortality ought to adapt to using these more rigorous 
approaches.  
 
H. Future directions for the field 
While there are currently a number of hot topics in the area of air pollution research, 
there has especially been a push over the last decade to more directly examine the health effects 
related to air pollution policies, often referred to as accountability research.11,59 This has been 
motivated by the fact that, to justify the implementation of lower air pollution standards, 
researchers will need to make the case to CASAC that stricter standards will result in benefits to 
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the nation beyond those gained from the current standards. This will require rigorous, policy-
relevant evidence that adds to the existing knowledge base, such as what can be obtained in an 
intervention analysis using modern quantitative (and especially causal inference) methods.10,59-61 
The call for stronger evidence is partly explained by the need to offset any costs that will 
be incurred as a result of implementing emission-reducing measures9 or of being labeled as non-
attainment. These costs have to be outweighed by demonstrated benefits to health and the 
environment, although evidence suggests that past particulate matter regulations have resulted in 
cost savings for the federal government. In fact, the Office of Management and Budget estimates 
that 1/3 to 1/2 of the total monetized benefits from significant federal regulations in the period 
2003-2012 came from reductions in emissions of particulate matter.59 Still, there is much 
resistance to implementing stricter air pollution policies. 
Taking into consideration the current political situation and the goal of air pollution 
researchers of obtaining more policy-relevant results, studies are needed that will overcome 
many of the limitations described above. In particular, studies will need to use more current data, 
be more generalizable, and use more modern quantitative methods that allow researchers to more 
closely estimate the real parameters of interest (although perhaps first the field ought to decide 







Figure 1.1 Median (IQR) of annual average PM2.5 concentrations measured at US EPA 







Figure 1.2 Annual average PM2.5 concentrations measured at EPA monitoring stations, 






CHAPTER II: STATEMENT OF SPECIFIC AIMS 
 
Our two specific aims and their accompanying hypotheses and rationale were as follows.  
These aims reflected our research goals in an ideal setting, and we attempted to carry them out as 
best as possible given the data. However, certain limitations resulted in small differences 
between the ideal and what was empirically testable, as described in the following chapters. 
 
A. Aims and hypotheses 
1. We aimed to summarize the natural history of US all-cause and cause-specific mortality risk 
between 1968 and 2016.  
We hypothesized that cumulative risk of all-cause mortality by age 85 would decrease 
over this time period while risk of respiratory mortality would increase and risk of 
cardiovascular mortality would decrease. 
2. For the years 2000-2016, we aimed to estimate the effect of lowering annual average PM2.5 
below a range of stricter standards (e.g. 10.0 µg/m3 and 5.0 µg/m3) on risk of all-cause and 
cause-specific mortality in all US counties, compared to the natural history.  
We hypothesized that mortality risk would be lower, and lifespans longer, under the 
interventions than the natural history and that reductions in mortality would become 




B. Aim 1 rationale 
Using only traditionally reported summary measures to describe the annual incidence of 
mortality or trends in mortality over time potentially disregards useful information available in 
vital statistics data. This is because all such incidence measures (and even other measures less 
commonly used for vital statistics like risk or median time to death) can be derived from another 
measure of mortality incidence: the survival curve. In fact, for any set of age-specific mortality 
rates there is an analogous survival curve on the age time scale. The survival curve and its 
complement, the cumulative incidence (risk) function are fundamental measures in epidemiology 
62-64, but they have been underused as a tool to describe national trends in mortality. This is 
despite requiring no further assumptions when calculating the survival curve beyond those made 
when calculating life expectancy (as described above). 
We therefore propose leveraging the risk function, calculated using annual vital statistics 
data, and additionally time-lapse animations of those curves as a new approach to summarize and 
visualize US mortality. Given that risk functions contain more information and are arguably 
more interpretable than other summary measures of incidence 62,64 (being an easily understood 
visual representation of the probabilities of mortality across the lifespan), examination and 
comparison of these curves over age and calendar time may reveal new information about US 
mortality trends. Not only could these curves supplement the way we use national vital statistics 
data and report annual mortality, but they can also be used in policymaking to generate the 
natural history of US mortality in analyses that seek to compare the observed mortality in the US 
to mortality patterns expected under a potential intervention. However, even with the 




approach should concur with the reported statistics, especially when examining all-cause and 
broad classes of cause-specific mortality. 
 
C. Aim 2 rationale 
The association between PM2.5 and mortality has clearly been established, and a 
regulatory system is in place that is designed to reduce exposure to PM2.5 on a national scale. As 
discussed above and as has been called for by many air pollution researchers, a next step is to 
conduct intervention analyses to inform policy makers when they next assess whether the 
NAAQS should be updated. We therefore sought to create an example for how one might 
conduct air pollution policy impact research, by assessing how intervening on annual average 
concentrations of PM2.5 such that they were below possible stricter air quality standards would 
affect all-cause, cardiovascular, and respiratory mortality compared to the natural history (that 
we described in aim 1). 
We additionally sought in our study to overcome several of the noted limitations of the 
PM2.5 literature, by using very recent exposure data (through 2016), the most widely 
generalizable population to date (in fact, the entire resident population of the contiguous US), 
and modern quantitative methods to answer an innovative question. To our knowledge, we are 
the first particulate matter study to apply the g-formula, a method we chose because it is ideally 
suited to comparing counterfactual outcomes under a hypothetical intervention to the natural 
history. We further believe our work to be directly policy-relevant. Our framework of comparing 
what was observed to what would have occurred if we intervened on PM2.5 also naturally lends 
itself to the estimation of absolute measures for the mortality-related health benefit resulting 




relate to inputs used in cost-benefit and decision-theory analyses than results obtained from more 
traditional approaches.61  
Our hypothesis was grounded in the current understanding of the dose-response 
relationship between PM2.5 and mortality, in particular the seeming lack of a threshold or safe 
level of PM2.5.
9,27,28 We thus expected that, as we continue to lower the PM2.5 annual average 





CHAPTER III: METHODS 
 
A. Synthetic cohort design 
Given our study aims, our ideal target population would be all US citizens since 1968, in 
whom we would observe prospectively their PM2.5 exposure and mortality experience from birth 
to death. Ignoring all realistic constraints, to observe this population’s intervention scenarios of 
interest, we would then go back in time and repeat the prospective observations after lowering 
ambient PM2.5 concentrations below certain standards. In the absence of time travel, we might 
have instead randomized the whole country, in communities, to either experience no intervention 
on exposure or to receive an exposure below the standard, and once again follow them 
prospectively until death. However, such randomization would be unethical, costly, and 
logistically impractical. Then, we might observe everyone and record their individual exposure 
to PM2.5 from birth to death. This, too, is unrealistic because it would be (1) infeasible to enroll 
the entire country (as in any of the above designs) and (2) too costly to record individual 
exposures on such a broad scale.  
In light of these considerations and the lack of any existing cohort that was truly 
generalizable to the entire US, we were here required to use a more creative design that 
leveraged the national data that does exist to answer our research question of interest. We should 
further mention that, as a result of data constraints, we altered our target population slightly to be 
the “resident population” of the entire contiguous US, in each year 1968-2016 (aim 1) and each 




not living abroad (with US territories considered abroad) for military or other purposes. This 
definition excluded nonresident aliens.  
To approximate our target populations, we borrowed the idea of a synthetic cohort from 
demography.3,65 A synthetic cohort is a cohort of arbitrary size underlying the life-table built 
using reported annual, age-specific rates of mortality. Alternatively, we can describe it as the 
cohort that could be said to exist if there was genuine exchangeability across birth cohorts (i.e., 
that the mortality rate for a 50-year-old in 1980 could be said to be the rate a person who was 10 
years old in 1980 would experience when they reached the age of 50 years). This is unlikely to 
be an assumption that holds up over long periods of time, but it is a useful fiction when 
attempting to understand trends in mortality in a population of interest. We then defined the 
synthetic lifespan (henceforth shortened to lifespan) as the mortality experience from birth to 
extinction of a single synthetic cohort. 
 For further information on our target population, Table 3.1 summarizes the basic 
demographic characteristics of the US population in select years during our study period. 
 
B. Description of the data 
To build the synthetic cohort in which we could estimate risk functions representing the 
mortality experience of the US population, we merged National Center for Health Statistics’ 
(NCHS) annual mortality and estimated mid-year population data.2,66,67 These data were 
provided in an aggregate format, with one record per year, county, age group (<1 year, 1-4, 5-9, 
10-14, 15-19, 20-24, 25-34, 35-44, 45-54, 55-64, 65-74, 75-84, 85+), sex (Male, Female), race 
(White, Black, or other), and, for 1999-2015, Hispanic or Latino ethnicity (yes, no, or 




included more detailed age information for deaths that occurred before 1 year of age, but we 
collapsed across those categories to align better with available population data. Causes of death 
were coded using the International Classification of Disease Eighth Revision (ICD-8, 1968-78), 
Ninth Revision (ICD-9, 1979-88), and Tenth Revision (ICD-10, 1989-2015).68 
Within each year and population subgroup, we created one record per possible outcome, 
each with an associated frequency equal to the number of individuals who experienced said 
outcome (e.g., the number of individuals who died). For all-cause mortality, the possible 
outcomes were death from any cause or survival. The number of individuals who survived was 
estimated by subtracting out the number of deaths from the mid-year population estimate. For 
cause-specific mortality, the possible outcomes were death from each of the causes of interest, 
death from any other cause, or survival. Based on our plans for aim 2, we examined two causes 
of interest: select cardiovascular mortality (ICD-8: 400-440; ICD-9: 401-440; ICD-10: I10-I70) 
and non-cancerous respiratory mortality (ICD-8/ICD-9: 460-519; ICD-10: J00-J99). Hereafter, 
we use the term non-cardiorespiratory mortality to refer to all other causes not included in our 
two categories of interest, although this final category will include select cardiovascular causes 
and lung cancer. Use of an aggregated data set in this manner (rather than creating one record per 
individual with an assigned outcome) greatly reduced the computational burden of the analysis. 
We fused this data set to information on our exposure and additional covariates. In this 
work, our exposure of interest was county-specific annual average PM2.5. Annual arithmetic 
average concentrations in µg/m3 were downloaded from the EPA’s Air Quality Systems 
Database, which includes data on PM2.5 concentrations measured at EPA monitoring sites across 
the US since 1999.69 We describe in the next section how this data was interpolated to obtain 




The variables considered as potential confounders were those we hypothesized affect the 
ambient levels of PM2.5 and mortality within a county. Based on key papers in the 
literature,17,19,22 we selected as our final covariate set several socioeconomic variables that could 
impact ambient levels of PM2.5 and mortality at the county level. We included year-specific 
median income, percent of residents with high school degree, percent of individuals aged 16 
years or older who were employed, and percent of households living below the poverty level. We 
obtained these covariates from the 2000 and 2010 US Censuses and the 2005-2016 American 
Community Surveys (ACS). For the ACS data, we pulled 1-year estimates for those counties that 
had a population greater than 65,000 and 5-year estimates for all counties (thus some counties 
had more than one record).70 Then, because of the gap between the 2000 Census and the start of 
the ACS in 2005, we interpolated values for each covariate such that we had one value per 
county per year using the natural cubic splines option in the SAS procedure EXPAND.71 For 
covariates that were proportions, we checked that the minimum value did not fall below zero and 
the maximum did not exceed one. 
Other important variables such as race, sex and Hispanic ethnicity were hypothesized to 
affect the outcome (based on our previous work) but not the exposure (as an artifact of the data, 
PM2.5 concentrations were equal across all, say, racial groups in a county). Thus, these were 
treated as potential effect measure modifiers (not confounders) in our analyses. See Figure 3.1 
for a conceptual diagram of the hypothesized causal relationships between the variables of 





C. PM2.5 exposure modeling 
 While the network of EPA monitors for PM2.5 is well dispersed across the country (see 
Figure 3.1 or recall Figure 1.2), their placement is based upon the population size and past air 
quality within a given geographical area. The location is further intended to reflect regional 
transport of ambient PM2.5.
9 Thus, the exact location of monitors could change from year to year, 
and, even more importantly for our purposes, there was not a monitor in every US county in 
every year. To interpolate concentrations in counties without a monitor, we used the 
geostatistical method Bayesian Maximum Entropy. This estimation approach allowed us to 
leverage the concept of a space/time random field, 𝑍(𝒑), to describe the randomness and 
correlation in PM2.5 measured at space/time points 𝒑 = (𝒔, 𝑡), where 𝒔 are the spatial coordinates 
of the monitor and 𝑡 is time in calendar year. Bayesian Maximum Entropy has been described in 
detail elsewhere;44,72,73 we summarize below the essential points for this analysis. 
Bayesian Maximum Entropy integrates general knowledge and site-specific knowledge 
about a space/time field using a mathematical framework. General knowledge can include the 
mean trend (e.g., that concentrations decreased over time) and covariance between points, which 
are modeled from the data. This information is used to build the prior probability density 
function that, outside of what is specified by the general knowledge, weakly constrains the data 
(i.e., maximizes information entropy74,75). Site-specific knowledge is the measured values, i.e. 
annual average PM2.5 concentration at each space/time point. The site-specific knowledge is 
integrated with the prior probability density function using a Bayesian epistemic knowledge 





For our implementation, the model inputs were the arithmetic annual average 
concentrations at each of the Environmental Protection Agency PM2.5 monitors labeled in the Air 
Quality Systems Database as measuring local conditions. We additionally pulled the spatial 
coordinates of the PM2.5 monitors, the number of measurements taken in a year, and the 
arithmetic standard deviation. Our estimation grid was defined by the spatial coordinates of the 
county population center (defined in 2015) at which we sought to estimate annual average PM2.5 
concentrations. We restricted our estimation (and thus our entire analysis) to counties within the 
contiguous US.  
First, to ensure normality of the exposure, we log transformed the data, such that 𝑌(𝒑) =
log(𝑍(𝒑)). We then obtained the global offset removed field 𝑋(𝒑) = 𝑌(𝒑) − 𝑚(𝒔, 𝑡), so that 
our estimation was conducted in a field that was more stable in space and time. The global offset 
was modeled using the formula 𝑚𝑌(𝒔, 𝑡) = 𝑚𝑠(𝒔) + 𝑚𝑡(𝑡), where 𝑚𝑠(𝒔) was the smoothed 
spatial mean component (calculated by applying an exponential spatial filter to the mean 𝑚𝑠𝑖 at 
each monitoring station i) and 𝑚𝑡(𝑡) was the smoothed temporal mean component (calculated by 
applying an exponential spatial filter to the mean 𝑚𝑡𝑗  at each time point j).  These two quantities 
were calculated as follows: 
𝑚𝑠(𝒔) =



















where s is a spatial location of interest, the index i refers to monitoring station i, 𝑚𝑠𝑖 is the mean 




monitoring i, t is a time of interest, the index j refers to monitoring event j, 𝑚𝑡𝑗  is the mean of 
log-PM2.5 measured at time j, 𝑑𝑡𝑗 is the time difference between time t and time j, the average m 
of all log-PM2.5 measured concentration was subtracted to avoid double counting when 𝑚𝑠(𝒔) 
and 𝑚𝑡(𝑡) were added, and the spatial range (𝑆𝑟𝑎𝑛𝑔𝑒) and temporal range (𝑇𝑟𝑎𝑛𝑔𝑒) governed the 
level of spatial and temporal smoothing, respectively. We chose to calculate a regionally defined 
global offset (rather than calculating a single mean for the entire US); consequently, we chose a 
𝑆𝑟𝑎𝑛𝑔𝑒 of 50 km. The specified 𝑇𝑟𝑎𝑛𝑔𝑒 was 3 years. 
Since we subtracted out the global offset, the mean tend for 𝑋(𝒑) was set to zero, and we 
found the nested exponential covariance model below to be a good fit for our data: 
𝑐𝑋(𝑟, 𝜏) = 0.0750[log⁡(µg/m














where 𝑟 is the spatial distance and 𝜏 the time distance between 𝒑 and 𝒑′. To interpret the 
meaning of the chosen model parameters, we specified that the variance of 𝑋(𝒑) was 
0.075(log⁡(µg/m3))2, and that 70% of the covariance in the field was explained by variation over 
a spatial range of 50 km and a temporal range of 14 years (i.e., city-level PM2.5 which changes 
only over long periods of time). Then, 30% of the covariance was explained by variation at a 
spatial range of 600 km and a temporal range of 1 year (i.e., region-level PM2.5 which could 
change more quickly). Using a nested covariance model with two terms allowed us to account 
for variation in PM2.5 over city- and region-level distances and over short and long periods of 
time. One of the advantages of space/time BME over other spatial models is this ability to 




Lastly, we considered a soft, probabilistic data approach because we wanted to account 
for the fact that measurements were not taken every day of the year (𝑛𝑖𝑡  being the number of 
measurements at monitor 𝑖 in year 𝑡), as has been done in previous studies.29,43,45 We treated the 
annual average from any monitor that recorded measurements at least every 3 days as hard, non-
probabilistic data (number of observations in the year ≥122). This cut-point was chosen because 
it reflects the federal reference method for PM2.5. Otherwise, data were treated as soft. 
Specifically, we assumed that the monitor data were normally distributed with mean equal to the 








where 𝑠𝑖𝑡 was the recorded arithmetic standard deviation. 
 
D. Estimation of the risk functions 
We followed the steps described below to estimate annual risk functions in the overall US 
population as well as risk functions within strata of key demographic variables. For all-cause 
mortality, we obtained risk curves stratified by sex alone; race, alone and jointly with sex; and 
US Census region, alone and jointly with sex. For cause-specific mortality, we obtained curves 
stratified by race and sex (but not jointly). In the stratified analyses, all steps were carried out 
separately within each stratum. Once the annual risk functions were estimated, the trends were 
primarily visualized using animations that progress through calendar time, although static 





1. All-cause mortality 
Within each of the 48 synthetic cohorts (i.e., one for each year 1968-2015), we used 
pooled logistic regression to estimate the probability of death from any cause in the 𝑘 = 1,… ,13 
age categories (conditional on survival to that age category):77,78 
logit(𝑃(𝑌 = 1)) = log (
𝑃(𝑌=1)
1−𝑃(𝑌=1)
) = 𝛼 + 𝛽1𝑎2 +⋯+ 𝛽12𝑎13, 
where 𝑌 = 1 signified death and 𝑎𝑘 were indicator variables for the age categories (𝑎1 being the 
reference category of <1 year). After estimating 𝛼 and 𝛽𝑘, we calculated the predicted 
conditional probabilities of death in each age category as shown below: 







, 𝑘 = 1
exp(𝛼 + 𝛽𝑘)
1 + exp⁡(𝛼 + 𝛽𝑘)
, 𝑘 > 1
 
 where 𝑇 was discrete time to death. The variance of 𝑃(𝑇 = 𝑘|𝑇 > 𝑘 − 1) was estimated using 
the delta method:79 










× 𝑉(𝛼), 𝑘 = 1
(
exp(𝛼 + 𝛽𝑘)




× 𝑉(𝛼 + 𝛽𝑘), 𝑘 > 1
 
where 𝑉(𝛼 + 𝛽𝑘) = 𝑉(𝛼) + 𝑉(𝛽) + 2Cov(𝛼, 𝛽).  
We then predicted the probability of dying at each age 𝑡 = 1,… ,120 years 𝑃∗(𝑇 = 𝑡|𝑇 >
𝑡 − 1). To do this, we first assigned the 𝑃(𝑇 = 𝑘|𝑇 > 𝑘 − 1) to the mid-point age of each age 
category. We rounded down if the mid-point was half an age, except in the case of deaths at <1 
year (i.e., the mid-point remained 0.5 years). Then, to inform prediction of the 𝑃∗(𝑇 = 𝑡|𝑇 > 𝑡 −
1) where 𝑡 ≥ 85, we created an artificial data point at age 120, representing a maximum lifespan 




we predicted the probability of death at each 𝑡 using a linear model regressing 𝑃(𝑇 = 𝑘|𝑇 > 𝑘 −
1) on age, with age flexibly modeled using restricted quadratic splines with 5 knots.81 The lowest 
age category was excluded to prevent the relatively high 𝑃(𝑇 = 1) from unduly influencing the 
model predictions. Additionally, to account for the 𝑉[𝑃(𝑇 = 𝑘|𝑇 > 𝑘 − 1)⁡] when estimating the 
𝑃∗(𝑇 = 𝑡|𝑇 > 𝑡 − 1) and their variances 𝑉[𝑃∗(𝑇 = 𝑡|𝑇 > 𝑡 − 1)], the linear regression model 
was weighted using inverse variance weights. 
Finally, we estimated cumulative incidence (risk) of mortality using the complement of 
the Kaplan-Meier (or product-limit) survival estimator:82,83 
𝑆(𝑡) = ∏{1 − 𝑃∗[𝑇 = 𝑡𝑖|𝑇 > (𝑡𝑖 − 1)]}
𝑖:𝑡𝑖≤𝑡
 
𝑅(𝑡) = 1 − 𝑆(𝑡) 
To estimate the survival variance, we applied a variant of Greenwood’s formula: 
𝑉[𝑆(𝑡)] = 𝑆(𝑡)2 ∑ (
1
1 − 𝑃∗(𝑇 = 𝑡𝑖|𝑇 > 𝑡𝑖 − 1)
)
2
× 𝑉[𝑃∗(𝑇 = 𝑡𝑖|𝑇 > 𝑡𝑖 − 1)]
𝑖:𝑡𝑖≤𝑡
 
where 𝑉[𝑃∗(𝑇 = 𝑡|𝑇 > 𝑡 − 1)] was the variance obtained from the linear model used to predict 
age-specific probabilities. Although not presented, we used the log-log method to calculate upper 
and lower pointwise 95% confidence interval limits for the risk function to ensure that we 
obtained confidence limits that fell within [0,1]. 
 
2. Cause-specific mortality 
 To estimate conditional probabilities of death from specific causes of death, the following 
multinomial pooled logistic regression model was run: 
𝜂𝑘𝑗 = log (
𝑃(𝑇=𝑘,𝐽=𝑗|𝑇>𝑘−1)
𝑃(𝑇=𝑘,𝐽=0|𝑇>𝑘−1)




where 𝛼𝑗 was the cause-specific intercept and 𝛽𝑘𝑗 the cause-specific coefficient for a given age 







The log odds for each age category and cause of death (𝜂𝑘𝑗) always used survival and the first 
age category (<1 year of age) as the referent. As a result, the log-odds for the reference category 
(𝜂10) was zero. The conditional mortality probabilities were then calculated as follows:
84 






Note that all-cause mortality is simply the special case of the above formula where 𝑗 can only be 
one or zero (dead or alive). Using these 𝜋𝑘𝑗 the conditional probability of dying from each cause 
at each age 𝑡 = 1,… ,120 (𝜋𝑡𝑗
∗ ) was then estimated using a similar spline approach as above, 
running one model per cause. Unlike above, when creating the artificial data point at age 120, the 
risk value assigned to each cause represented the proportion of deaths at age 120 expected for 
that cause. Additionally, we required that ∑ 𝑃∗(𝑇 = 120, |𝑇 > 119)𝑗 = 1. Here, we chose 
(based on the data) 0.1 for respiratory mortality and 0.45 each for cardiovascular and all other 
causes of death.  
After the 𝜋𝑡𝑗
∗  were obtained, we broke ties between causes of death by taking a random 
draw from a uniform distribution and adding that value between (0,1) to age. For deaths at <1 
year of age, we simply assigned the value of the draw. Every record received a new random draw 
(i.e., for a given age and year, one draw per cause of death). This method assumed there was no 




Finally, the risk functions for each cause of death were obtained using the Aalen-
Johansen estimator:56,57,83,85 
𝑅(𝑡, 𝑗) = ∑ 𝜋𝑖𝑗𝑆(𝑡𝑖 − 1)
𝑖:𝑡𝑖≤𝑡
 
where 𝑆(𝑡𝑖 − 1) was all-cause survival through the time point prior to 𝑖. This estimator has the 
attractive property that ∑ 𝑅(𝑡, 𝑗)𝑗 = 𝑅(𝑡). We estimated the variance for the Aalen-Johansen 
using an extension of Greenwood’s formula:83 
𝑉[𝑅(𝑡, 𝑗)] = ∑ [𝑆(𝑡𝑖 − 1)𝜋𝑖𝑗]
2
(𝑛𝑖 − 1)𝑛𝑖
−3𝑑𝑖𝑖:𝑡𝑖≤𝑡   
⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡+∑ 𝑆(𝑡𝑖 − 1)
2(1 − 2𝜋𝑖𝑗)(𝑛𝑖 − 1)𝑛𝑖
−3𝑑𝑖𝑗𝑖:𝑡𝑖≤𝑡 , 
where 𝑛𝑖 was the number at risk at time 𝑡𝑖 and 𝑑𝑖 was the number of deaths from any cause at 
time 𝑡𝑖 (estimated by multiplying 𝜋𝑖𝑗 and 𝑛𝑖). As a result of the shift from age categories to 
continuous age and our method of breaking ties between causes, we had to estimate each 𝑛𝑖 by 
first setting it equal to the population total in the data for the first age of a given age category and 
then subtracting the estimated 𝑑𝑖−1 from 𝑛𝑖−1 for each age in that category. 
Although not presented, we obtained point-wise 95% confidence intervals for each curves 
using 𝑆𝐸[𝑅(𝑡, 𝑗)] = √𝑉[𝑅(𝑡, 𝑗)] and truncated the limits such that they did not exceed [0,1]. 
Ideally, we would have propagated the uncertainty of the estimated 𝜋𝑖𝑗 through this step, but, to 
our knowledge, there is no form of the variance for the Aalen-Johansen estimator that would 
allow this (in contrast to the variant of Greenwood’s formula for the Kaplan Meier allowing us to 





E. Estimation of intervention effects 
 In aim 1, we were interested in estimating risk functions under the natural history (i.e. 
mortality as it was recorded under the observed levels of PM2.5). In aim 2, we were interested in 
estimating risk functions under a potential intervention where we set counties that exceeded a 
PM2.5 standard to meet the standard. Counties that met the standard kept their natural history 
exposure. Standards considered were 10 µg/m3 (the European Union annual standard) and 5 
µg/m3 (as an example of a strict, if perhaps unfeasible, standard). In essence, we imagined a 
world in which the original 1997 standard for PM2.5 was not set at 15 µg/m
3 and then in 2005 
lowered to 12 µg/m3, but rather one where the standard was originally set at a stricter value and, 
by the start of our analysis in 2000, all counties had achieved that standard.   
To compare risk under the natural history to risk under one of these intervention scenarios, we 
used Robin’s generalized computational algorithm formula (g-formula),53 or more accurately the 
parametric extended g-formula.86 Our particular implementation of the g-formula was seen as an 
expansion of the first step from aim 1 for estimating risk functions in synthetic cohorts (the step 
where we estimated 𝑃(𝑇 = 𝑘, 𝐽 = 𝑗|𝑇 > 𝑘 − 1)) to allow for estimation of conditional survival 
probabilities under different exposure scenarios, i.e. survival under observed PM2.5 
concentrations or under the potential standards. When we completed our stratified analyses, we 
included only those data records within a particular population subgroup.  
First, we modeled log PM2.5 concentration using a linear regression model with linear and 
quadratic terms for all continuous variables (percent with high school education, percent below 
poverty level, and percent employed). After we shifted from obtaining annual to whole study 
period results, we additionally included a linear term for calendar year. Potential effect measure 




For this model, we included log-transformed median income because we observed that the 
distribution of income was skewed. We further included first-order interaction terms to increase 
the flexibility of the model. 
 Second, we modeled the outcome using pooled logistic regression for all-cause mortality 
and polytomous pooled logistic regression for the cause-specific mortality. As with the exposure 
model, this model included all potential confounders (linear and quadratic terms) but additionally 
included the potential effect measure modifiers. Unlike above, we dichotomized income based 
on whether the county’s median income was below the nation-wide median income for a 
particular year. We again included first-order interaction terms, but, for our overall model, did 
not include interaction terms with sex and race.  
 Third, we took a Monte Carlo sample of our data of size 50,000 records. We sampled 
observations at the level of a county demographic group, e.g. we might have randomly selected 
the record for Black non-Hispanic women from Orange County, NC. Once a record was selected, 
we grabbed their covariate data from every year. Within the Monte Carlo sample, we simulated a 
record’s potential exposure and potential outcome under the natural history and under the 
intervention scenario using the coefficients from the above-described exposure and outcome 
models. The primary difference between the two scenarios was in the exposure used to predict 
the outcome: either the natural history exposure predicted from the observed data and estimated 
coefficients or the intervention exposure set at a particular value. If the annual average PM2.5 
concentration for a given record under the natural history was above the standard being 
considered, the exposure was set to be at the standard; otherwise, the exposure was left as it was 
under the natural history. We then averaged the conditional mortality probabilities across year 




probability (i.e., the age-category-specific mortality hazard). Note that in this implementation, 
we did not directly model any of the potential confounders, but rather treated them as “baseline” 
variables. Given our synthetic cohort structure and inability to track individuals across years, we 
deemed this appropriate. 
Both the natural course and intervention hazards were then input into the last two steps of 
our risk function approach: (1) interpolation using splines to estimate age-specific hazards and 
(2) estimation of the cumulative incidence function using the Kaplan-Meier estimator for all-
cause mortality or the Aalen-Johansen estimator for cause-specific mortality. Finally, we 
compared the natural history and intervention scenarios by taking the risk difference (RD) at 
each age, with 95% confidence intervals estimated using the standard deviation of 200 bootstrap 
resamples. 
 
F. Supplementary analyses 
 
1. Aim 1 supplementary analyses 
For our first supplementary analysis, we used different time aggregations than single 
years, including 5-year blocks (or quinquennia), decades, and the entire 1968-2015 period. 
Analyses were otherwise identical to those described above. We also restricted our data to the 
post-1999 period and compared the all-cause and cause-specific risk curves stratified in those 
who reported being of Hispanic or Latino ethnicity to the risk in those who were not. We did not 
examine those with undeclared ethnicity. Next, we repeated the non-stratified analysis for a more 
detailed cause of death outcome, wherein we pulled out from the cardiovascular and respiratory 




mortality due to heart disease (coronary and ischemic: ICD-8/ICD-9 410-414, 429; ICD-10 I20-
25), stroke (ICD-8/ICD-9: 430-438; ICD-10: I60-69), other cardiovascular causes, chronic lower 
respiratory diseases (ICD-8: 490-493; ICD-9: 490-494,496; ICD-10: J40-47), other respiratory 
causes, and lastly all other causes of death. 
Last, we repeated our cause-specific mortality analyses after applying compatibility ratios 
to the mortality count data to account for the fact that the death classifying system changed 
throughout the study period. This was mainly necessary for the transition from ICD-9 to ICD-10 
codes because of notable changes in cause of death coding. These compatibility ratios (which are 
calculated by comparing the number of deaths assigned to a certain death type under the new 
system to the number that would have been assigned to a classification as similar as possible to 
that type under the old system) were provided by NCHS in data documentation and were used to 
weight the mortality counts from the ICD-9 coding era to better reflect what the count would 
have been under the ICD-10 era. For instance, the compatibility ratio for chronic lower 
respiratory diseases was 1.0478, indicating that the ICD-10 classification contained more deaths 
than the complementary classification under ICD-9 coding. As no compatibility ratios were 
given for ICD-8, the same ratios were applied to the cause-specific deaths in the period 1968-78 
as were used for the ICD-9 coding. 
 
2. Aim 2 supplementary analyses 
 In supplementary analyses, we repeated our approach stratified by sex and race/ethnicity 
to investigate whether there was potential effect measure modification by those variables. We 




possibility that the composition of PM2.5 varied by region. The rationale being that the effect 
might differ by region if the exposure we were examining meaningfully differed.  
We further assessed whether results would differ if we assigned exposure under the 
intervention scenario not to be equal to the standard but rather to be a draw from the posterior 
distribution from our exposure modeling, if we had truncated that distribution at the standard. 
While setting the exposure at the standard is a method that has been used in prior studies asking 
similar questions,58 we believe this supplementary analysis is a closer approximation to how 
intervening to reduce PM2.5 below a specified standard would work in real life. The 
concentration that a county which had previously been above the standard would achieve under 
the intervention is more likely to be some concentration below the standard (rather than exactly 
the standard), with how close that concentration is to the standard being a reflection of what the 
county’s value was before that standard was set. In doing this analysis, we sought to check 
whether assigning exposure in this manner would change the results relative to how exposure 
assignment had been conducted in the main analysis. 
 
G. Initial checks on the aim 2 models 
Prior to examining the estimated RD functions, we compared the natural course risk 
function estimated through the g-formula to results we had obtained in aim 1, as a check for 
possible statistical model misspecification.87 In general, we saw good agreement, with the same 
trends in all-cause and cause-specific mortality as have been reported by us and others.87,88 
However, within certain population subgroups (namely, the small and highly heterogeneous 
Other race category), we found our models to be unstable, and the estimated natural course risk 




to not present their results. Then, as in aim 1, we initially obtained RD functions by year. Upon 
examination of the year-specific functions, though, we noticed no clear chronological trend and 
attributed any differences by year that did exist to statistical noise. Given these findings, we 
instead ran our g-computation approach using data from all years and included calendar year as a 
covariate when modeling the exposure and the outcome. 
 
H. Statistical software 
 Data management, risk function estimation, and implementation of the g-formula were 
done in SAS version 9.4 (SAS Institute, Cary, NC). Animations of risk functions (as well as their 
static counterparts) and risk difference function figures were also created in SAS. We used 
Matlab version R2016A (The MathWorks, Inc., Natick, MA) with the BMELIB 2.0c library to 
carry out Bayesian Maximum Entropy for our exposure modeling. Matlab was also used to 











Table 3.1. Size and demographics of the US population in select yearsa   
Characteristic 
1970 1985 2000 2015 
N % N % N % N % 
































































Hispanicb     35,305,818 12.5 56,338,521 17.6 
aCalculated using county-level population totals in the NCHS data 





























CHAPTER IV: RESULTS 
 




Objectives. To use dynamic visualizations of mortality risk functions over both calendar 
year and age as a way to estimate and visualize patterns in US lifespans. 
Methods. We built 49 synthetic cohorts, 1 per year 1968 to 2016, using National Center 
for Health Statistics (NCHS) mortality and population data. Within each cohort, we estimated 
age-specific probabilities of dying from any cause (all-cause analysis) or from a particular cause 
(cause-specific analysis). We then used Kaplan-Meier (all-cause) or Aalen-Johansen (cause-
specific) estimators to obtain risk functions. We illustrated risk functions using time-lapse 
animations. 
Results. Median age at death increased from 75 years in 1970 to 83 years in 2015. Risk 
by aged 100 years of cardiovascular mortality decreased (from a risk of 55% in 1970 to 32% in 
2015), whereas risk attributable to other (i.e., nonrespiratory and noncardiovascular) causes 
increased in compensation. 
                                                 
1 Section A of Chapter IV previously appeared as a brief article in the American Journal of Public Health. The 
original citation is as follows: Rudolph JE, Cole SR, Edwards JK, Whitsel EA, Serre ML, Richardson DB. Using 
Animations of Risk Functions to Visualize Trends in US All-Cause and Cause-Specific Mortality, 1968-2016. Am J 




Conclusions. Our findings were consistent with the trends published in the NCHS 2015 
mortality report, and our dynamic animations added an efficient, interpretable tool for visualizing 
US mortality trends over age and calendar time. 
 
2. Introduction 
Traditionally, mortality in the United States has been reported using age-standardized 
rates and life expectancy. However, using only these or similar summary measures to describe 
trends in mortality potentially disregards useful information available in vital statistics data. This 
is because all such incidence measures (and even other measures less commonly used, such as 
risk or median time to death) can be derived from another measure of mortality incidence: the 
survival function. The survival function and its complement, the cumulative incidence (risk) 
function, are fundamental measures in epidemiology62,64; however, such measures remain 
underused as a tool to describe national trends in mortality despite requiring no further 
assumptions than those made when calculating life expectancy (chiefly, the assumption of 
exchangeability of currently observed data with what an individual will experience in the 
future).3,5,65 
We therefore propose using the risk functions, and especially time-lapse animations of 
those functions, as an approach to summarize and visualize US mortality. The proposed risk 
functions contain more information and are arguably more interpretable than are other incidence 
measures,62,64 and we foresee them as having uses beyond simply summarizing trends in 







We describe in brief the main concepts underlying our risk function animations. (Chapter 
III provides more detail.) 
Our target populations were the US resident populations in each year from 1968 to 2016. 
Because we could not follow all US citizens from birth to death across a half century, we used 
the idea of a synthetic cohort.3,65 This is the cohort that could be said to exist if, within a single 
year (or other slice of time), there was exchangeability across birth cohorts. Although unlikely to 
be an assumption that holds up over long periods, it is a useful fiction when summarizing 
mortality trends in a population of interest. 
We obtained mortality and demographic data for our target populations from the National 
Center for Health Statistics (NCHS) compressed mortality and population files.2,66,67 Then, 
within year-specific synthetic cohorts, we did the following: 
1. estimated the probability of dying in an age category, conditional on surviving to that 
age category; 
2. interpolated the step 1 results to obtain the age-specific probability of dying, 
conditional on surviving to a specific age; and 
3. estimated the risk functions, using the step 2 results as age-specific hazards. 
We then combined the annual risk functions to create dynamic, time-lapse animations. 
(For all animations mentioned below as well as additional animations, see the paper in press at 
the American Journal of Public Health.) We carried out the 3 steps for all-cause mortality as 
well as for 3 categories of mortality (select cardiovascular, all respiratory, and all other causes). 







Despite the use of different methodologies, our results lined up well with several of the 
findings presented in the NCHS final 2015 mortality report.5,80 For instance, our estimated 
average time to death for all-cause mortality in the overall US population was identical (to one 
tenth of 1%, or 0.001) to the reported life expectancies from birth for 2014 and 2015. 
As a demonstration, we highlight 1 of our animations, namely the cause-specific risk 
functions for the overall US population stacked together (movie S5B or, for a static 
summarization, Figure 4.1). We gleaned several pieces of information from this image. First, as 
is made clear from the way the outermost curve (representing all-cause mortality risk) gradually 
shifted to the right as the years progressed, the US lifespan lengthened over the period from 1968 
to 2016. Additionally, until the late 1980s, the clear leading cause at aged 100 years was 
cardiovascular mortality (1970: 55%; 1985: 49%), although its risk was similar to respiratory 
mortality until aged 40 years and its risk was lower than were other causes of death until aged 80 
years. After the late 1980s, though, other causes of death began to have the greatest risk at aged 
100 years (2000: 48%; 2015: 56%). We can also see that there was a slight increase in risk of 




The presentation of US mortality statistics by animations of risk functions could enhance 
the way mortality trends are routinely reported by allowing us to present a greater amount of 




as a function of both age and calendar time, which is more informative than is collapsing to a 
single summary measure (e.g., the age-standardized rate) and then seeing how that measure 
changed over time. Moreover, risks, being merely proportions, are considered more interpretable 
than are rates.62,64 
Estimation of risk functions formally accounting for competing risks attributable to 
multiple causes of death is another novel addition to the way cause-specific mortality statistics 
are routinely reported. The Aalen-Johansen estimator, a generalization of the Kaplan-Meier 
estimator, allowed us to estimate cause-specific risk, so that the risks were not conditional on not 
having experienced a competing risk up to a certain time point.57,89 To contrast, none of the 
measures currently used to report cause-specific mortality trends explicitly account for the fact 
that 1 cause of death prevents an individual from dying from another cause.90 
Lastly, our approach for assessing trends in mortality concords with the statistics and 
trends reported by NCHS without requiring an external data source. The method that NCHS uses 
to smooth age category data to continuous age among those older than 85 years (before 2008, 
those 66 years or older) involves merging the NCHS data with Medicare data, and Medicare data 
are not open access.80 Our method, conversely, required only the NCHS data and thus could 
easily be used by other researchers to replicate our results or estimate different risk functions of 
interest. 
Despite its utility, our approach had limitations. Perhaps most important was the potential 
for misclassification of death totals (with the amount of misclassification known to differ by 
race) and of underlying cause of death, both of which were inherited from the data sources. 
Furthermore, we had to rely on extrapolation (using spline models) to determine the shape of the 




in more recent calendar years. Finally, we estimated the risk functions in synthetic cohorts 
(rather than birth cohorts), which complicates their interpretation. We argue, though, that 
synthetic cohorts already underlie all life tables constructed for reporting annual US mortality, 
and the resulting statistics are crucial for examining mortality trends. Also, to instead estimate 
mortality risk functions in existing birth cohorts would have perhaps been less useful because the 
data were aggregated (and thus had no ability to account for immigration and emigration) and 
because the data included no birth cohort observed fully from birth to extinction. 
We call for an increased focus on the estimation of risk functions for assessing US 
mortality trends and the use of animations of those functions to dynamically visualize trends in a 
highly interpretable fashion. Although we did not describe this, our approach could easily be 
applied to and extended by studies examining (in a highly generalizable fashion) factors that 
could reasonably affect the observed trends. For instance, one could imagine examining the 
mortality risk curves before and after a major federal policy change to see whether that policy 
affected mortality, or one could investigate how mortality risk might have differed under a 
counterfactual public health intervention. 
 
B. Effect of potential fine particulate matter national air quality standards on the US lifespan 
 
1. Overview 
We investigated how risk of mortality would have differed in the US from what was 
observed if we intervened to set county-level ambient concentrations of fine particulate matter 
(PM2.5) below two potential air quality standards: 10 and 5 µg/m
3. Our target population was the 




cohort constructed from National Centers for Health Statistics mortality and population data. Our 
PM2.5 data were obtained from the Environmental Protection Agency’s Air Quality Systems 
Database and were interpolated over the entire contiguous US. To estimate risk under the natural 
history (i.e., under a 15 then 12 µg/m3 standard) and the two intervention scenarios, we used the 
generalized computational algorithm formula, controlling for confounding by county-level 
socioeconomic factors (income, education, and poverty). We estimated that, in the overall US 
population, risk of all-cause mortality would unexpectedly increase under both the 10 and 5 
µg/m3 standards compared to the natural history. Breaking mortality down by causes, the 
estimated increase in all-cause mortality risk was driven by an increase in non-cardiorespiratory 
mortality, while risk of cardiovascular mortality decreased under the intervention scenarios. 
These results, however, were small and imprecise. We further suspect that we have not met the 




Over the last decade, many air pollution epidemiologists have been calling for an 
increased focus on research questions that move beyond traditional exposure-outcome 
assessments, which have constituted the bulk of the literature to date.11,59 They argue instead that 
we should investigate the health effects of air pollution policies more directly. The push for such 
policy impact research has been motivated in part by the fact that, in the current policy climate, 
researchers will need to provide increasingly strong evidence that the implementation of stricter 




standards.10,59,60 Such evidence will need to be acquired in a rigorous manner and be useful for 
policy makers.61  
With a goal of directly examining the effects of air pollution policy, one question we 
might ask is: how would trends in important health outcomes (say, mortality) have differed from 
what was observed if we had intervened to ensure the entire US had met a specified air quality 
standard. Given the nature of this question, we might prefer to consider an air pollutant that has 
both well-established health effects and federal regulations upon which we might intervene. 
Particulate matter (PM) presents itself as one such exemplary exposure. 
As one of the six criteria air pollutants, PM is monitored and regulated under the 1970 
Clean Air Act by the United States (US) Environmental Protection Agency (EPA). National 
Ambient Air Quality Standards have been set for ambient concentrations of PM and are re-
examined approximately every 5 years to ensure they align with the current scientific knowledge 
base. At least in part due to these federal regulations, ambient concentrations of PM have 
steadily dropped in recent years.9,10 For example, the EPA estimates that, between 2000 and 
2015, daily concentrations of PM with an aerodynamic diameter <10 µm (PM10) and PM with an 
aerodynamic diameter <2.5µm (PM2.5) improved by 34% and 40%, respectively.
91  Even so, PM 
remains a ubiquitous exposure, and importantly a large body of evidence from multiple scientific 
fields has established its adverse environmental and health effects, even at low 
concentrations.9,27,28 Out of all sub-classifications of PM, PM2.5, also referred to as fine PM, has 
been most consistently associated with all-cause, cardiovascular, and respiratory mortality 
following both acute and long-term exposure.15-26 The evidence is so strong that the EPA has 
declared PM2.5 to have a causal effect on both mortality and cardiovascular outcomes (and likely 




We therefore sought to create an example for how one might conduct air pollution policy 
impact research, by assessing how intervening on annual average concentrations of PM2.5 such 
that they were below possible stricter air quality standards would affect all-cause, cardiovascular, 
and respiratory mortality. To accomplish this, we compared mortality risk functions under these 
potential intervention scenarios to the observed risk functions representing the exposure and 
mortality experience of the US resident population, 2000-2016. 
 
3. Methods 
Study sample and key data 
 Our target population for this analysis was the resident population of the contiguous US 
in the years 2000-2016. The generation of annual synthetic cohorts meant to represent this target 
using National Center for Health Statistics (NCHS) data has been described in detail elsewhere.87 
In short, we used the NCHS annual mortality and mid-year population counts to calculate year- 
and age-specific mortality hazards and then used those hazards to calculate a cumulative risk 
function within each year. The synthetic cohort underlying this risk function is the cohort that 
could be said to exist if birth cohorts were exchangeable. For example, we assume the hazard for 
a 50-year-old in 2000 is the hazard a 30-year-old in 2000 would experience if they lived to 50, 
even though we do not observe them longitudinally age from 30 to 50. While such an assumption 
does not reflect reality, it is a widely employed, useful fiction for describing trends in national 
mortality over time and, in fact, is the current standard when calculating life expectancy. 
 The NCHS data were aggregated by year, county, age-category, race, Hispanic ethnicity, 
and sex; mortality data were additionally given by underlying cause of death, coded using 




all-cause mortality, select cardiovascular mortality (ICD-10 I10-I70), and non-cancerous 
respiratory mortality (J00-J99). We refer to all other causes of mortality not of direct interest 
here as non-cardiorespiratory mortality (although this category does include some cardiovascular 
causes as well as lung cancer). We then linked the NCHS data to other publically available data 
sets to obtain the exposure and other, important covariates. Our exposure of interest was PM2.5, 
which has been measured at EPA monitoring sites across the US since 1999. Annual average 
concentrations in µg/m3 were downloaded from the EPA’s Air Quality Systems Database.69 In 
the next section, we describe how we used this data to estimate county-specific annual average 
concentrations.  
County-level covariate information was drawn from the 2000 and 2010 US Censuses and 
from the 2005-2015 American Community Surveys (ACS). Given the lack of covariate data for 
certain counties in certain years, we interpolated values where necessary using natural cubic 
splines.71 The variables considered as potential confounders were those we hypothesized affect 
the ambient concentrations of PM2.5 and mortality within a county. Accordingly, we obtained 
data on primarily socioeconomic factors: median household income, percent of families living 
below the poverty line, percent of individuals over 16 years of age employed, and percent of 
individuals who graduated high school. This covariate set was comparable to similar PM2.5 
studies.17,19,20,22 Other important variables such as race, sex and Hispanic ethnicity were 
hypothesized to affect the outcome (based on our previous work) but not the exposure (as an 
artifact of the data, PM2.5 concentrations were equal across all, say, racial groups in a county). 
Thus, these demographic variables were treated as potential effect measure modifiers in our 






 While EPA monitors for PM2.5 are well dispersed across the country (see Supplementary 
Figure 1), their placement is based upon the population size and past air quality within a given 
geographical area. The location is further intended to reflect regional transport of ambient 
PM2.5.
9 Thus, the exact location of monitors can change from year to year, and, even more 
importantly for our purposes, there was not a monitor in every US county in every year. To 
interpolate concentrations in counties without a monitor, we used the geostatistical method 
Bayesian Maximum Entropy. This approach allowed us to leverage the concept of a space/time 
random field to describe the variability and correlation in PM2.5 measured at specific points in 
space and time. Bayesian Maximum Entropy has been described in detail elsewhere;44,72,73 we 
summarize below the essential points for this analysis.  
Bayesian Maximum Entropy integrates general knowledge and site-specific knowledge 
about a space/time field using a mathematical framework. General knowledge can include the 
mean trend (e.g., that concentrations decreased over time) and covariance between two points, 
which are modeled from the data. This information is used to build the prior probability density 
function that, outside of what is specified by the general knowledge, weakly constrains the data 
(i.e., maximizes information entropy74,75). Site-specific knowledge is the measured values, i.e. 
annual average PM2.5 concentration at each space/time point. The site-specific knowledge is 
integrated with the prior probability density function using a Bayesian epistemic knowledge 
integration rule,72,76 and a posterior probability density function is obtained at each specified 
estimation point. 
Here, our data were input as “soft”, probabilistic data (as opposed to “hard” data which 




taken every day of the year and thus the annual averages were based on <365 days of data.29,43,45 
We additionally log transformed the PM2.5 data, and we subtracted out the mean trend so that we 
estimated county-level concentrations in a field that was more stable in space and time. Lastly, 
we specified a two-term, exponential model to describe the exposure covariance, which allowed 
us to account for variation in PM2.5 over city- and region-level distances and over short and long 
periods of time. Our model specifications are given in greater detail in the Appendix. 
 
Outcome models 
 Following the estimation of county-specific exposures, we estimated risk functions under 
the natural history (i.e. mortality as it was recorded under the observed PM2.5 concentrations) and 
under a potential intervention where we set counties that exceeded a specified PM2.5 standard to 
meet the standard. Counties that met the standard kept their natural history exposure. We 
imagined a world in which the original 1997 standard for PM2.5 was not set at 15 µg/m
3 and then 
in 2005 lowered to 12 µg/m3, but rather one where the standard was originally set at a stricter 
value and, by the start of our analysis in 2000, all counties had achieved that standard.  Standards 
considered were 10 µg/m3 (the European Union annual standard) and 5 µg/m3 (as an example of 
a strict, if perhaps unfeasible, standard). 
To compare risk under the natural history to risk under one of these intervention 
scenarios, we used Robin’s generalized computational algorithm formula (g-formula),53 or more 
accurately the parametric extended g-formula.86 In previous work,87 we outlined an approach to 





1. Estimate the probability of dying in an age category, conditional on surviving to that 
age category. 
2. Interpolate the step 1 result to obtain the age-specific probability of dying, conditional 
on surviving to a given age. 
3. Estimate the cumulative risk functions, using the step 2 results as age-specific 
hazards. 
Here, we expanded the first step to allow for estimation of conditional survival probabilities 
under different exposure scenarios (i.e., survival under observed PM2.5 concentrations or under 
the counterfactual standards). Instead of only estimating the age-category-specific conditional 
mortality probabilities using pooled logistic regression (with no covariates besides age in the 
model), we estimated both exposure and outcome. Log PM2.5 concentration was modeled using 
linear regression, and all confounders were included in the model. Potential effect measure 
modifiers that we hypothesized did not affect the exposure were not included. Mortality was 
modeled using pooled logistic regression (all-cause mortality) or multinomial pooled logistic 
regression (cause-specific mortality), now including in the model all confounders and effect 
measure modifiers in addition to age. 
 We then generated a Monte Carlo sample, sampling with replacement 50,000 
observations (an observation being defined as a county demographic group with all of its age 
category and calendar year data). Within this sample, we simulated a record’s potential exposure 
and potential outcome under the natural history and under the intervention scenario using the 
coefficients from the exposure and outcome models. The primary difference between these two 
scenarios was that, under the intervention scenario, exposure was set rather than predicted from 




history was above the standard being considered, the exposure was set to be at the standard; 
otherwise, the exposure was left as it was under the natural history. Finally, before proceeding 
with the above listed step 2, we averaged the mortality probabilities across records so that we 
had only one hazard per year and age category. Steps 2 and 3 then proceeded exactly as in our 
previous work. To compare results under the natural history to those obtained under the 
intervention scenarios, we took the risk difference (RD) at each age, with 95% confidence 
intervals estimated using the standard deviation of 200 bootstrap resamples. 
 In our first supplementary analysis, we stratified by US Census region as one way to 
account for the possibility that the composition of PM2.5 varied by region. The rationale being 
that the effect might differ by region if the exposure composition meaningfully differed. We 
further assessed whether results would differ if we assigned exposure under the intervention 
scenario not to be equal to the standard but rather to be drawn from the posterior distribution 
from our exposure modeling, if we had truncated that distribution at the standard. While setting 
the exposure at the standard is a method that has been used in prior studies asking similar 
questions,58 we believe this supplementary analysis is a closer approximation to how intervening 
to reduce PM2.5 below a specified standard would work in real life. The concentration that a 
county which had previously been above the standard would achieve under the intervention is 
more likely to be some concentration below the standard (rather than exactly the standard), with 
how close that concentration is to the standard being a reflection of what the county’s value was 
before that standard was set. 
Then, prior to examining the RD functions, we compared the natural course risk function 
estimated through the g-formula to results we had previously obtained, as a check for possible 




all-cause and cause-specific mortality as have been reported by us and others.87,88 However, 
within certain population subgroups (namely, the small and highly heterogeneous Other race 
category), we found our models to be unstable, and the estimated natural course risk functions 
matched less well. We thus chose to not trust our inferences within said categories and to not 
present their results. Lastly, as in our previous work, we initially obtained RD functions by year. 
Upon examination of the year-specific functions, though, we noticed no clear chronological 
trend, i.e. no effect measure modification by year. Given these findings, we instead ran our g-
computation approach using data from all years and included calendar year as a covariate when 
modeling the exposure and the outcome. 
 
4. Results 
In our previous work, we reported that the median age at death increased from 80 years in 
2000 to 83 years in 2015; the average age at death (life expectancy) increased from 76.8 years to 
78.8 years over the same period.87 Women lived longer than men, and White Americans had 
longer lifespans than Black Americans (although the small, highly heterogeneous Other race 
category had the highest life expectancy). Now, combining data across the calendar years 2000-
2016, we found that the overall median age at death was 82 years and the average age of death 
(life expectancy) was 78.1 years.  Risk of all-cause mortality by age 80 was 47% (2000: 51%; 
2015: 44%).  
In the same time period, annual average concentrations of PM2.5 decreased dramatically 
(Table 4.1). We estimated that the national average PM2.5 concentration was 12.02 µg/m
3 in 2000 
but 7.94 µg/m3 in 2016. If we compare our estimated values to the two hypothetical PM2.5 




the 5 µg/m3 standard. In comparison, in 2016 95.7% of counties met the 10 µg/m3 standard and 
8.1% met the 5 µg/m3 standard.  
There were also shifts in the demographic and socioeconomic characteristics of the US 
population during our time period of interest. The proportion of the population that self-reported 
as a racial and ethnic minority increased. For example, Black Americans made up 13.0% of the 
US population in 2000 and 14.0% in 2015; the Hispanic American population (regardless of 
race) grew from 12.6% to 17.6% of the US population between 2000 and 2015. The national 
median of county-specific median annual household incomes increased from $33,673 in 2000 to 
$46,404 in 2016. Furthermore, in 2000 11% of US families lived below the poverty line, 77% of 
the population had graduated from high school, and 61% of those 16 or older were employed 
(these being the national average of county averages). In 2016, those characteristics were 12%, 
86%, and 59%, respectively. 
In the overall US population, we estimated that risk of all-cause mortality (Table 4.1) 
increased by key ages under both of the stricter PM2.5 standards and that life expectancy (Table 
4.2) decreased, although results were highly imprecise. Under the natural history as estimated by 
the g-formula, all-cause mortality risk by age 85 was 62.5% and life expectancy was 77.8 years 
(median age at death: 82 years). Under the 10 µg/m3 standard, those estimates were 62.6% and 
77.7 years (median: 82 years), respectively; under the 5 µg/m3 standard, they were 62.9% and 
77.6 years (median: 82 years), respectively. Looking at the risk difference function (Figure 4.2), 
we can see that all-cause mortality risks were further from the null under the 5 µg/m3 standard 
than under the 10 µg/m3 standard across the age spectrum, but the confidence intervals entirely 
overlapped (and crossed the null). The largest all-cause mortality RDs observed for the two 




µg/m3 standard being 0.09% (95% CI: -0.03%, 0.22%) and 0.35% (95% CI: -0.24%, 0.95%) 
higher than under the natural history, respectively.  
Once we broke down all-cause mortality into our three cause-specific categories (Figure 
4.3), we saw that the increase in risk under the two intervention scenarios was largely due to an 
increase in risk of non-cardiorespiratory mortality. During our study period, risk by age 100 of 
non-cardiorespiratory mortality was greater than either cardiovascular or respiratory mortality 
(52% versus 37% and 9%, respectively); thus, the non-cardiorespiratory RD function had the 
greatest influence on the all-cause RD. However, we did observe a decrease in risk of 
cardiovascular mortality under both interventions, with the reduction in risk at age 85 being 
further from the null under the 5 µg/m3 standard (RD: -1.03%, 95% CI: -1.27%, -0.79%) than 
under the 10 µg/m3 standard (RD: -0.19%, 95% CI: -0.24%, -0.15%). 
Finally, in our supplementary analysis where we no longer set a county’s exposure at the 
standard but rather assigned their exposure under the intervention to be a draw from the posterior 
distribution from our exposure model, we found that our all-cause mortality RD functions under 
the intervention scenarios were similar but slightly further from the null than those seen in the 
main analysis. Under the 10 µg/m3 standard, risk of all-cause mortality at age 85 was 0.13% 
(95% CI: -0.05%, 0.31%) higher than the under natural history; under the 5 µg/m3 standard, all-
cause mortality risk was 0.37% (95% CI: -0.27%, 1.01%) higher. 
 
5. Discussion 
In this paper, we estimated how mortality risk would have differed compared to what was 
observed if we intervened such that all US counties had an annual average PM2.5 concentration 




greater than (but close to and with 95% confidence intervals that crossed) the null for the 10 
µg/m3 and for the 5 µg/m3 standard. The increase in all-cause mortality risk seemed to be driven 
by an increase in non-cardiorespiratory risk under the intervention scenarios; in contrast, risk of 
cardiovascular mortality decreased under the intervention scenarios.  
Even disregarding the lack of precision, the results seen here were unexpected because 
they run directly counter to nearly all associations reported in the literature. While one could say 
this is because we were estimating a different parameter (i.e., an intervention effect where we set 
counties to be below a PM2.5 standard rather than the more traditional rate ratio for a 10 µg/m
3 
increase in PM2.5 concentration), we have strong reason to suspect the results as reported are 
uninterpretable due to a violation of our identification assumptions (discussed below). 
Additionally, while we reported the overall results as they currently stand, we had originally 
intended to also report subgroup analysis results, but our lack of confidence in the overall results 
has led us to defer those analyses until we refine our approach. 
We should further mention that even should we be able to estimate our intervention 
effects validly, the magnitude of our RDs will always be relatively small. (Although we argue 
that, given the size of the US population, even small RDs for a nationwide intervention will still 
be of public health importance.) Moreover, as mentioned above, it will be difficult to directly 
compare our RDs to any effect estimate reported by previous papers because those are generally 
expressed as, for example, the rate ratio for a 10 µg/m3 change in PM2.5 concentration. In our 
comparison, very few counties would have their ambient concentrations change by 10 µg/m3 
even under the 5 µg/m3 standard, and some counties would have experienced no change in their 
ambient concentrations. As such, one would expect our estimates to be even smaller than those 




increase in mortality rates for a 10 µg/m3 increase in PM2.5.
22 Similarly, we expect our life 
expectancy results will be closer to the null than those reported in Correia et al. Using data from 
545 US counties in the years 2000-2007, Correia et al. estimated a 0.35 year increase in life 
expectancy per 10 µg/m3 decrease in PM2.5 concentration.
24  
 Our work as proposed had several limitations. First, we expect some non-differential 
misclassification. Although modeling concentrations in counties without an EPA monitor 
allowed us to extend the population under consideration from those who live near monitors to the 
entire contiguous US, there will be uncertainty associated with those predicted values that will 
increase as distance from monitor increases. This would be the case even if we had supplemented 
our exposure models with data from sources like satellites or the EPA’s Community Multi-Scale 
Air Quality Modeling System. While including these data alongside the monitor measurements 
in our approach might have resulted in improved exposure prediction, both of those data sources 
would have brought with them additional assumptions (because both involve additional 
modeling). Besides, prior work showed that Bayesian Maximum Entropy models using only 
monitor measurements compared well against models that brought in additional exposure data.92 
Beyond misclassification of the exposure, rates obtained using NCHS mortality and population 
data are known to be underestimates for Native Americans and Asians (11%) and overestimates 
for Whites and Blacks.68 Assignment of a single, underlying cause of death is also subject to 
error. These latter sources of misclassification as they pertain to our synthetic cohorts have been 
described in more detail elsewhere.87  
Second, we used exposure, outcome, and covariate data that were aggregated by county 
and year, and, as a result, could not examine seasonal or within-county variations. However, we 




investigating how intervening on an individual’s personal exposure would have affected 
mortality trends on a granular (e.g., day) time scale. We were instead interested in examining 
how intervening to set annual, ambient PM2.5 concentrations at a specified, stricter standard 
would have affected national mortality trends. The use of county-level, annual average exposures 
better matches the exposure measurements that regulatory agencies would be using to determine 
whether a region was meeting the air pollution standards or not; as in our study, they would not 
have access to actual individual exposures.  
Third, our approach was highly dependent on the use of parametric models. If we 
incorrectly specified any of the models we fit (the exposure linear regression, outcome logistic 
regression, spline interpolation of age-category hazards, etc.), our results could be biased. To 
mitigate this limitation, we attempted to be as flexible as our models would allow, including first 
order interaction terms as well as polynomials of continuous covariates. However, we cannot 
rule out that model misspecification bias is contributing to the un-interpretability of our results, 
and we intend to investigate the issue further. Also related to this dependence on modeling, we 
should emphasize that our mortality and population data had as its highest age category “85 
years or older.” Consequently, the risk function for this age category was entirely dependent on 
both the spline interpolation model and our decision to include an observation at age 120 with a 
conditional mortality probability of one. Any results obtained at ages 85 and older should thus be 
cautiously interpreted. 
Fourth, we made a number of assumptions which could affect the interpretation of our 
results. We assumed that it was the reduction in PM2.5 that was important for mortality, rather 
than the actual interventions that bridge the setting of an air pollution standard to achievement of 




reduced coal burning, targeting of a component of PM2.5, or reductions in other pollutants that 
react in the air to form components of PM2.5) did not themselves matter. 
Relatedly, we assumed in our main analyses that the effect on mortality would not change 
based upon the composition of PM2.5, which in reality is a complex mixture of different particles. 
Put another way, we assumed that any variation in our treatment was irrelevant.93 To investigate 
potential violations of this assumption, we estimated risk differences stratified by US Census 
region (a variable we did not consider as a potential effect measure modifier due to our previous 
finding that the mortality risk function varied little by region). As can be seen in Figure 4.4, with 
the exception of the South, results from each region were similar to what was observed in the 
overall US population, at least for the 5 µg/m3 standard. While we do not report confidence 
intervals for these results, we suspect that they are as (if not more) imprecise than those seen in 
the main analysis. On the basis of these findings (and our general validity concerns), we cannot 
draw any strong conclusions regarding whether differences in PM25 composition by region 
affected our results. 
We also assumed that there was no interference between counties. It is possible that 
exposure in one county could affect risk of mortality in another county. For example, an 
individual could be exposed due to work or other activities to the adjacent county’s exposure but 
then die in his or her own county. Air pollution is also not static; weather patterns could result in 
emissions from a more highly polluted county drifting into a nearby county. If that occurs a few 
days a year, it is unlikely to greatly affect the annual average concentration, but a large spike in 
air pollution could potentially have significant effects on annual mortality.  
Lastly, we assumed that we had exchangeability between counties, conditional upon the 




confounders of the relationship between PM2.5 and all-cause mortality, between PM2.5 and the 
causes of interest, or between PM2.5 and the competing causes of death beyond those included in 
our analysis. The violation of this assumption is the one we believe is most likely behind our 
unexpected results. In particular, we suspect (based on various checks on our data and models, 
such as estimation of propensity scores and analyses that set all US counties to experience PM2.5 
concentrations greater than the current national standard) that we do not have proper comparator 
counties with low PM2.5 concentrations for the urban counties that have high PM2.5 
concentrations but also have very high life expectancy (e.g., Los Angeles county). These unique 
outliers also perhaps have undue influence over our g-formula outcome model, which considers 
the actual number of individuals who died. We thus propose, in future work, to refine our 
approach to exclude the most populous and most population dense US counties for whom good 
comparators are unlikely. While this will reduce our generalizability, we believe the potential 
improvement to internal validity will justify the restriction. 
Furthermore, while we included in our models potential confounders commonly 
accounted for in the air pollution literature, these were largely suspected confounders for the 
relationship between PM2.5 and cardiorespiratory mortality. We have potentially not controlled 
for all the confounders of the relationship between PM2.5 and non-cardiorespiratory mortality 
(our competing risk, which includes a heterogeneous mix of causes like cancer, accidents, 
infectious diseases, etc.), and it was this cause of death category that drove the estimated 
increases in risk of mortality under the intervention scenarios. Our proposed exclusion of unique, 





We also did not here account for any co-pollutants which might be confounding the effect 
of PM2.5 on mortality. In particular, we might be vulnerable to unmeasured confounding that 
could be controlled for by including ozone in our models. Given that two components of PM2.5 
(volatile organic compounds and nitrogen oxides) are involved in the atmospheric processes 
which produce ozone and previous work has shown an association between ozone and mortality, 
ozone could sit on a confounding pathway. Future work could either model ozone in a similar 
fashion as we did here for PM2.5 such that these data could be included. 
One might question, though, why we did not include in our analyses proxies for many of 
the individual variables one might expect to be controlled for in a study of air pollution and 
mortality. The ambient concentration of PM2.5 where an individual lives is one factor influencing 
his or her personal exposure level, alongside smoking, time spent near traffic, or occupational 
exposures. These determinants of exposure and others such as body mass index and physical 
activity are also likely confounders of the effect of personal exposure on mortality. However, as 
with the data aggregation, careful examination of the parameter we were estimating reveals that 
control of such covariates was unnecessary. Our exposure of interest was the ambient pollution 
concentrations themselves and not the ambient concentrations as a proxy for individual exposure. 
Thus, these individual factors become confounders of a mediator (personal exposure) and the 
outcome and do not need to be controlled for as long as they do not also affect the ambient PM2.5 
concentrations. To put it another way, our parameter of interest could be seen as analogous to the 
intention-to-treat effect in randomized clinical trials.94 Unlike in a trial, though, ambient PM2.5 
concentrations were not randomized, and we had to control for confounders affecting ambient air 
pollution and mortality, such as county socioeconomic characteristics. The above described 




ambient PM2.5 and mortality saw little difference when individual clinical or behavioral factors 
were included in their models.18  
Despite its limitations and assumptions, our study is the first to look at the effect of 
intervening on PM2.5 concentrations such that they were below certain standards in the entire 
contiguous US. We leveraged national vital statistics data to create a synthetic cohort 
representing the entire resident population of the contiguous US in the years 2000-2016. While 
an unconventional study design, our data fusion of multiple large, publically available data sets 
allowed us to obtain results that were more generalizable to our target population than an 
analysis that could have been conducted in any currently existing cohort (or indeed any air 
pollution studies that have been previously conducted). It is not just that our population was not 
restricted by factors like age,22,23,33,51 race,19,20,35 sex, occupation, or geographic 
region,21,33,34,36,41,42 but we also used more recent PM2.5 data than the bulk of the literature 
examining the long term effects of this particular criteria air pollutant (much of which used data 
from 2002 or earlier). 11,15,17,19-22,25,33,39,40  
We still believe, pending the planned refinements, that our work has the potential to have 
a wide public health impact. Exposure to PM2.5 has been demonstrated to have an effect on 
mortality, and a policy framework is in place to limit emissions of this air pollutant with the goal 
of reducing ambient concentrations to below the set national air quality standards. Our study 
question, methods, and population were purposefully formulated to be more relevant to policy 
makers than traditional exposure-outcome analyses61 and to answer the recent calls for studies 
looking directly at the health effects of air pollution policies.11,59 We used modern quantitative 
methods not previously used in the literature and leveraged the causal inference framework to 




threats to our validity that we could (and could not) overcome. Our approach serves as an 
example for how one could provide additional, valuable insight on the effectiveness of potential 
stricter standards for PM2.5 in reducing all-cause and cause-specific mortality nationwide. 
Ultimately, our approach could inform policymakers when they next assess whether lowering the 








Figure 4.1 Risk of mortality attributable to select cardiovascular, all respiratory, and all 
other causes as a function of age: United States, 1968–2016 
 
Note. Risk functions are displayed as the fraction of the risk attributable to all-cause mortality. 
These risk functions were estimated in the 1968 and 2016 synthetic cohorts, representing the 

















10 µg/m3 (%) 
Counties ≤ 
5 µg/m3 (%) 
2000-2016 10.13 0.23 30.57 47.74 2.58 
2000 12.02 3.37 24.29 25.06 0.35 
2005 11.32 3.04 21.53 29.81 0.61 
2010 9.62 0.31 17.99 48.33 2.67 
2015 8.24 2.27 15.81 88.05 6.54 
a As estimated at the US Census county population center using Bayesian Maximum Entropy, with the 
concentrations in µg/m3 back-calculated from the model’s estimated concentrations in log(µg/m3) and the 









Table 4.2. Comparing risk of all-cause and cause-specifica mortality under two potential air pollution standards to the risk 
under the natural course in the overall US population, 2000-2016  
Cause of Death Scenario 




















NC 12.70 0  46.71 0  99.11 0  
10 µg/m3 12.73 0.03 -0.01, 0.08 46.79 0.08 -0.02, 0.18 99.12 0.01 -0.00, 0.02 
5 µg/m3 12.83 0.13 -0.09, 0.35 47.02 0.30 -0.19, 0.79 99.13 0.02 -0.02, 0.07 
Cardiovascular  
NC 2.63 0  12.58 0  37.13 0  
10 µg/m3 2.59 -0.04 -0.06, -0.03 12.47 -0.11 -0.14, -0.08 36.81 -0.32 -0.39, -0.25 
5 µg/m3 2.39 -0.24 -0.31, -0.17 12.00 -0.58 -0.73, -0.43 35.51 -1.62 -1.96, -1.29 
Respiratory 
NC 0.44 0  3.63 0  8.69 0  
10 µg/m3 0.44 0.00 0.00, 0.00 3.65 0.02 0.01, 0.03 8.75 0.06 0.04, 0.08 
5 µg/m3 0.45 0.01 0.00, 0.01 3.73 0.10 0.05, 0.14 9.00 0.32 0.22, 0.42 
Non-cardio-
respiratoryb  
NC 7.72 0  26.28 0  52.43 0  
10 µg/m3 7.77 0.05 0.01, 0.08 26.40 0.12 0.04, 0.20 52.68 0.26 0.18, 0.34 
5 µg/m3 7.94 0.21 0.05, 0.38 26.82 0.54 0.15, 0.92 53.71 1.28 0.90, 1.67 
Abbreviations: RD, risk difference; CI, confidence interval; NC, natural course 
aCause-specific mortality defined using the International Classification of Diseases, 10th Revision codes (select cardiovascular mortality: I10-I70; respiratory mortality: 
ICD-10 I10-I70) 









Table 4.3. Comparing life expectancy under the 
natural course and under the intervention 






Natural Course 77.757 0 
10 µg/m3 77.729 -0.027 
5 µg/m3 77.649 -0.107 









Figure 4.2. Risk difference as a function of age comparing all-cause mortality risk under 
two potential PM2.5 standards to risk under the natural history in the overall US 
population, 2000-2016   
 
Note: A positive risk difference indicates that risk of mortality was greater under the intervention 
scenario than under the natural history. Shaded regions represent 95% confidence intervals (dark 








Figure 4.3. Risk difference as a function of age comparing cause-specific mortality under 
the natural course to mortality under two potential PM2.5 standards in the overall US 








Figure 4.4. Risk difference as a function of age comparing all-cause mortality risk under 








CHAPTER V: CONCLUSIONS 
 
Our overarching goal in this dissertation was to inform future air pollution policymaking 
by answering the call to more directly estimate the effects of policies. We proposed an approach 
not yet explored in the PM2.5 literature, one that compared mortality trends under hypothetical 
PM2.5 standards to mortality trends under the natural course. We sought to do this using all 
public access data. In carrying out this work, we broke our larger aim into two components: 
estimation of the natural history of national mortality and PM2.5 exposure and estimation of 
counterfactual mortality under the intervention scenarios to which we would compare the natural 
history. We view our work as presented here, particularly the latter component, as experimental 
– as a first take on how one might estimate intervention effects on ambient air pollution 
concentrations. Given its experimental nature, the limitations of our approach as proposed 
became apparent as our work was in progress, and we will seek to overcome these limitations 
moving forward as we refine our approach in future work (see section D below).  
 
A. Summary of main results 
In aim 1, we focused on a new approach to summarize and visualize the natural history of 
US all-cause and cause-specific mortality, 1968-2016. Through dynamic animations of mortality 
risk functions over both calendar year and age as well as summary measures derived from those 
risk functions, we highlighted several major trends in mortality. Despite the use of different 




well as different smoothing techniques to obtain age-specific estimates), our results lined up well 
with several of the findings presented in the NCHS final 2015 mortality report.5,80 For instance, 
our estimated average time to death for all-cause mortality in the overall US population was 
identical to one decimal place to the reported life expectancies from birth for 2014 and 2015. The 
NCHS report also described many of the same trends across sex, racial, and ethnic lines, 
including the decreases in mortality disparities between men and women and between non-
Hispanic Black and non-Hispanic White populations. In terms of cause-specific mortality, NCHS 
similarly showed that rates of cardiovascular mortality (and especially heart disease mortality) 
decreased dramatically since the 1970s.5 
In aim 2, we compared the natural history described in aim 1 against the risk function that 
might have occurred if we had intervened to set all US counties to meet two stricter PM2.5 
standards: 10 and 5 µg/m3. We estimated that risk of all-cause mortality would increase under 
both intervention scenarios compared to the natural history, with risk differences that were 
further from the null under the 5 µg/m3 standard compared to the 10 µg/m3 standard (although 
the confidence intervals overlapped and crossed the null). When examining cause-specific 
mortality, we saw that the increase in all-cause mortality was driven by an increase in non-
cardiorespiratory mortality; risk of cardiovascular mortality, on the other hand, decreased under 
bother interventions. However, we have strong concerns regarding the validity of our results. 
This was on account of three major issues we identified: the direction of the all-cause mortality 
concentration-response being opposite what has been reported in the literature, the imprecision 
of our results under the 5 µg/m3 standard (driven by a potential lack of positivity), and concerns 
regarding our ability to achieve exchangeability between counties. These issues were first 




that they extended to our overall results as well. We discuss these concerns and their relation to 
our future plans below. 
 
B. Strengths 
 There were several ways in which our presentation of US mortality statistics enhanced 
the way mortality trends have been routinely reported. When we used the risk function and 
animations of risk functions as the central reporting tool, we were able to present a greater 
amount information more efficiently. For instance, we could observe from the risk functions how 
mortality trends changed as a function of both age and calendar time, which is more informative 
than collapsing to a single summary measure (say, the age-standardized rate) and then seeing 
how that measure changed over time. Moreover, risks, being merely proportions, are considered 
to be more interpretable than rates.62,64 
Building on this, while the usual summary measures can be derived from the more 
informative risk function, we also obtained measures less commonly reported like age-specific 
cumulative risks. Risk functions further lend themselves to the estimation of median age at death, 
which might better capture the true midpoint of the human lifespan than average age at death due 
to the left-skewed distribution of time to death. Additionally, if one were looking for a more 
stable summary measure to examine over calendar time, one might wish to estimate and report 
the median rather than the average, given that the former is less susceptible to (potentially 
uninformative) small variations in annual mortality. However, if one instead did want a measure 
more sensitive to small trends, average age at death would be more appropriate and can also be 




 Then, the estimation of risk functions formally accounting for competing risks due to 
multiple causes of death was a potentially novel addition to the way cause-specific mortality 
statistics are routinely reported. The Aalen-Johansen estimator, which is a generalization of the 
Kaplan-Meier estimator, allowed us to estimate risk functions in the presence of competing risks, 
such that those risks were not conditional on not having experienced a competing risk up to a 
given time point.57,83 To contrast, cause-specific mortality has historically been reported using 
counts (to rank causes of death), age-standardized rates (to look at trends over time), and 
proportions of all deaths in a year contributed by each cause.5 None of these measures explicitly 
account for the fact that one cause of death prevents an individual from dying from another 
cause.90 In addition to being theoretically appealing, we intend to investigate in future work 
whether accounting for competing risks could result in important differences in the trends of a 
particular cause of death. 
 Lastly, our approach for assessing trends in mortality has good concordance with the 
statistics and trends reported by NCHS without requiring an external data source. The method 
that NCHS uses to smooth age category data to continuous age among those older than 85 
(before 2008, those 66 or older) involves merging the NCHS data with Medicare data, and 
Medicare data are not open access.80 Our method, on the other hand, only requires the NCHS 
data and thus could be easily used by other researchers to replicate our results or estimate 
different risk functions of interest to them. 
When it comes to aim 2, our study was the first to look at the effect of intervening on 
PM2.5 concentrations such that they were below certain standards in the entire contiguous US. 
We leveraged national vital statistics data to create a synthetic cohort representing the entire 




design, this allowed us to obtain results that were more generalizable to our target population 
than an analysis that could have been conducted in any currently existing cohort (or indeed any 
air pollution studies that have been previously conducted). It is not just that our population was 
not restricted by factors like age,22,23,33,51 race,19,20,35 sex, occupation, or geographic 
region,21,33,34,36,41,42 but we also used more recent PM2.5 data than much of the literature 
examining the long term effects of this particular criteria air pollutant (much of which used data 
from 2002 or earlier). 11,15,17,19-22,25,33,39,40 Furthermore, our study question, methods, and 
population were purposefully formulated to be more relevant to policy makers than traditional 
exposure-outcome analyses61 and to answer the recent calls for studies looking directly at the 
health effects of air pollution policies.11,59  
 
C. Limitations 
 Despite its potential utility, our approach to summarizing mortality trends in aim 1 had its 
limitations. Perhaps most important was the potential for misclassification of two major types, 
inherited from the data sources. Misclassification of race is known to occur on death certificates, 
notably among Native Americans and Asians, and young white and black men tend to be 
underrepresented in the Census population counts that make up the denominator of the mortality 
rates. It is estimated that this misclassification results in an overestimation (1% in whites; 5% 
blacks) and underestimation (21% in Native Americans; 11% in Asians) of the annual mortality 
rates.68 Assignment of an underlying cause of death is also known to be subject to 
misclassification.95-99 Our use of broader mortality classes in the main analysis may have 
minimized this error (because one cardiovascular cause might be mistaken for another but is less 




considered. For cardiovascular mortality, several studies have shown that death certificate 
records for the causes of interest here, such as heart disease and stroke, perform fairly well 
compared to more intensive review.100,101 The results of validation studies for respiratory 
mortality have been more mixed.95,97,99 While misclassification is unlikely to entirely explain the 
trends seen here (for example, a decrease in over-reporting of cardiovascular causes could have 
contributed but is unlikely to fully explain the decrease in risk of cardiovascular mortality), we 
might still have reported results biased due to misclassification. Future work could examine the 
extent to which such misclassification might alter our findings. 
Beyond misclassification, there were several other limitations of our aim 1 approach. We 
had to rely on modeling to determine the shape of the risk function past age 85, and, in more 
recent calendar years, this was where the bulk of US mortality occurred. Indeed, we saw in the 
later years that the median age at death in some demographic groups was greater than 85 years. 
The risk function for this age category was entirely dependent on both the spline interpolation 
model and our decision to include an observation at age 120 with a conditional mortality 
probability of one. Consequently, any results obtained at ages 85 or more should thus be 
cautiously interpreted. This modeling was necessary, though, given the data structure. Our choice 
to display the risk function through age 100 also meant that we primarily focused on trends 
occurring in the second half of the synthetic lifespan, as they were most visible. We did not 
explore trends at younger ages, but this could be done using our approach by simply restricting 
the risk functions through the age of interest. 
It is further worth mentioning reasons US vital statistics data have not been routinely 
used to estimate the type of risk functions we propose here. A possible argument against 




within a nation) are dynamic as a result of immigration and emigration. We thus lack a carefully 
enumerated denominator defined at baseline and followed over time and are instead forced to use 
the mid-year population size. The former is often thought to be necessary for estimating risks, 
but it is relatively standard in survival analysis to use extensions of the Kaplan-Meier to estimate 
risk in the presence of late entries (and in a sense our synthetic cohort is mostly comprised of 
individuals “late entering” on the age time scale). As to the latter, mid-year population counts are 
validly used to estimate mortality rates, and the life tables built from those rates have long been a 
tool of demographers to examine survival even in dynamic populations.3 One might then argue 
that our risk functions do not reflect risks experienced by any existing birth cohort, which 
renders their interpretation ambiguous. While it is true that these risks apply only to a synthetic 
rather than a birth cohort, synthetic cohorts underlie all life-tables constructed for reporting 
annual US mortality, and the resulting statistics are crucial for examining mortality trends. We 
also point out that to instead estimate mortality risk functions in existing birth cohorts would 
have perhaps been less useful because the data were aggregated (if a member of the birth cohort 
were to emigrate, the data would not catch it) and because data began in 1968 (so no birth cohort 
has yet been observed fully from birth to death). 
 Our aim 2 work also had several limitations. First, we expect some non-differential 
misclassification of the exposure, in addition to the other sources of misclassification discussed 
above. Although modeling concentrations in counties without an EPA monitor allowed us to 
extend the population under consideration from those who live near monitors to the entire 
contiguous US, there will be uncertainty associated with those predicted values that will increase 
as distance from monitor increases. This would be the case even if we had supplemented our 




Quality Modeling System. While including these data alongside the monitor measurements in 
our approach might have resulted in improved exposure prediction, both of those data sources 
would have brought with them additional assumptions (because both involve additional 
modeling). Besides, prior work showed that Bayesian Maximum Entropy models using only 
monitor measurements compared well against models that brought in additional exposure data.92  
Second, we used exposure, outcome, and covariate data that were aggregated by county 
and year, and, as a result, could not examine seasonal or within-county variations. However, we 
carefully articulated our study question to match this aggregation in our data. We were not 
investigating how intervening on an individual’s personal exposure would have affected 
mortality trends on a granular (e.g., day) time scale. We were instead interested in examining 
how intervening to set annual average ambient PM2.5 concentrations at a specified, stricter 
standard would have affected national mortality trends. The use of county-level, annual average 
exposures better matches the exposure measurements that regulatory agencies would be using to 
determine whether a region was meeting the air pollution standards or not; as in our study, they 
would not have access to actual individual exposures.  
Third, our approach was dependent on the use of parametric models. If we incorrectly 
specified any of the models we fit (the exposure linear regression, outcome logistic regression, 
spline interpolation of age-category hazards, etc.), our results could be biased. To mitigate this 
limitation, we attempted to be as flexible as our models would allow, including first order 
interaction terms as well as polynomials of continuous covariates.  
Fourth, we made a number of assumptions that could affect the interpretation of our 
results. We assumed that it was the reduction in PM2.5 that was important for mortality, rather 




that standard at the county level (like new technologies or trade incentives to decrease emissions, 
reduced coal burning, targeting of a component of PM2.5, or reductions in other pollutants that 
react in the air to form components of PM2.5) did not themselves matter. Relatedly, we assumed 
in our main analyses that the effect on mortality would not change based upon the composition 
of PM2.5, which in reality is a complex mixture of different particles. Put another way, we 
assumed that any variation in our treatment was irrelevant.93  To investigate potential violations 
of this assumption, we performed an analysis stratified by US Census region (a variable we did 
not consider as a potential effect measure modifier due to our previous finding that the mortality 
risk function varied little by region). As can be seen in Figure 3, with the exception of the South, 
results from each region were similar to what was observed in the overall US population, at least 
for the 5 µg/m3 standard. While we do not report confidence intervals for these results, we 
suspect that they are as (if not more) imprecise than those seen in the main analysis. On the basis 
of these findings (and our general validity concerns), we cannot draw conclusions regarding 
whether differences in PM25 composition by region affected our results. 
We also assumed that there was no interference between counties. It is possible that 
exposure in one county could affect risk of mortality in another county. For example, an 
individual could be exposed due to work or other activities to the adjacent county’s exposure but 
then die in his or her own county. Air pollution is also not static; weather patterns could result in 
emissions from a more highly polluted county drifting into a nearby county. If that occurs a few 
days a year, it is unlikely to greatly affect the annual average concentration, but a large spike in 
air pollution could potentially have significant effects on annual mortality.  
Lastly, we assumed that we had exchangeability between counties, conditional upon the 




confounders of the relationship between PM2.5 and all-cause mortality, between PM2.5 and the 
causes of interest, or between PM2.5 and the competing causes of death beyond those included in 
our analysis. The violation of this assumption is the one we believe is most likely behind our 
unexpected results. In particular, we suspect (based on findings described in the next section) 
that we do not have proper comparator counties with low PM2.5 concentrations for the urban 
counties that have high PM2.5 concentrations but also have very high life expectancy (e.g., Los 
Angeles county). These unique outliers also have perhaps undue influence over our g-formula 
outcome model, which considers the actual number of individuals who died and who lived.  
Furthermore, while we included in our models potential confounders commonly 
accounted for in the air pollution literature, these were largely suspected confounders for the 
relationship between PM2.5 and cardiorespiratory mortality. We have potentially not controlled 
for all the confounders of the relationship between PM2.5 and non-cardiorespiratory mortality 
(our competing risk, which includes a heterogeneous mix of causes like cancer, accidents, 
infectious diseases, etc.), and it was this cause of death category that drove the estimated 
increases in risk of mortality under the intervention scenarios. Our proposed exclusion of unique, 
highly populated counties may or may not mitigate this potential violation of the exchangeability 
assumption. 
We also did not here account for any co-pollutants which might be confounding the effect 
of PM2.5 on mortality. In particular, we might be vulnerable to unmeasured confounding that 
could be controlled for by including ozone in our models. Given that two components of PM2.5 
(volatile organic compounds and nitrogen oxides) are involved in the atmospheric processes 




ozone could sit on a confounding pathway. Future work could either model ozone in a similar 
fashion as we did here for PM2.5 such that these data could be included. 
One might question, though, why we did not include in our analyses proxies for many of 
the individual variables one might expect to be controlled for in a study of air pollution and 
mortality. The ambient concentration of PM2.5 where an individual lives is one factor influencing 
his or her personal exposure level, alongside smoking, time spent near traffic, or occupational 
exposures. These determinants of exposure and others such as body mass index and physical 
activity are also likely confounders of the effect of personal exposure on mortality. However, as 
with the data aggregation, careful examination of the parameter we were estimating reveals that 
control of such covariates was unnecessary. Our exposure of interest was the ambient pollution 
concentrations themselves and not the ambient concentrations as a proxy for individual exposure. 
Thus, these individual factors become confounders of a mediator (personal exposure) and the 
outcome and do not need to be controlled for as long as they do not also affect the ambient PM2.5 
concentrations. To put it another way, our parameter of interest could be seen as analogous to the 
intention-to-treat effect in randomized clinical trials.94 Unlike in a trial, though, ambient PM2.5 
concentrations were not randomized, and we had to control for confounders affecting ambient air 
pollution and mortality, such as county socioeconomic characteristics. The above described 
causal structure could perhaps explain why past studies investigating the association between 
ambient PM2.5 and mortality saw little difference when individual clinical or behavioral factors 





D. Further investigations into violations of key aim 2 assumptions and next steps 
 Above we discussed the standard identification assumptions for causal inference and their 
potential violations in the context of our aim 2 analyses. While it is often the case in science that 
we cannot say with certainty we have met these identification conditions, over the course of our 
work on this project, we became concerned with our ability to say we could even approximate 
them. We first became aware of a serious problem when the intervention effects estimated within 
racial and ethnic sub-groups were extreme and when we estimated that the all-cause mortality 
risk for Hispanic Americans was much higher under the intervention scenario than under the 
natural history. In response, we estimated propensity scores (dichotomizing PM2.5 exposure as 
above or below the specified standard) both overall and within population subgroups and 
discovered through examination of their distributions that we were likely violating the 
conditional exchangeability with positivity assumption. We further theorized, based on 
examination of maps of where the Hispanic American populations are concentrated,102 that we 
likely were missing important unmeasured confounders that would allow us to validly compare 
mortality in urban areas with high air pollution (e.g., Los Angeles county) to more rural areas 
with lower air pollution (e.g., counties along the Mexican-American border). We also questioned 
whether we would ever be able to achieve exchangeability, regardless of the number of 
socioeconomic variables we included in our models. It should also be mentioned that, while we 
originally considered this only in the context of our Hispanic sub-group analysis, we later came 
to the opinion that this is likely also a threat to the validity of our overall analyses. 
 There were several other supplemental analyses we conducted related to potential 
violations of the conditional exchangeability with positivity assumption, but these resulted in 




consideration using the estimated propensity scores mentioned above. If a county had a stabilized 
inverse probability weight greater than 20 or less than 1/20 within a given year, it was removed 
from the analysis. In our overall analysis, only 0.09% of records had such extreme weights, and 
our point estimates were unchanged. We further wished to determine whether excluding very 
small rural counties (which might not have good comparators and which are also more likely to 
have misclassified exposures) would affect our results. To do this, we restricted to the 
approximately 1600 most populous counties that accounted for 95% of the 2016 US population. 
Again, our results were largely unchanged. 
 We further investigated the susceptibility of our results to model misspecification bias, in 
particular how specifying the exposure term in our g-formula outcome model affected our 
results. From our reading of the literature, there are currently two considered models for the 
shape of the PM2.5 concentration-response relationship: linear and supra-linear.
28 The former 
states that log survival is proportional to PM2.5 concentration while the latter specifies that log 
survival is proportional to log(PM2.5) concentration. Based on exploratory analyses that showed 
annual average PM2.5 concentrations were more log-normally distributed in some years, we used 
log(PM2.5) concentrations first in our Bayesian Maximum Entropy modeling and again in the g-
formula step that required modeling of the exposure using linear regression. When it came to our 
outcome models, we originally included linear, quadratic, and cubic terms for all continuous 
variables including log(PM2.5) concentration as well as interactions between the linear terms. 
This decision was made to increase the flexibility of our model. Despite what the literature says, 
we were not comfortable including only a linear term because we do not believe the world works 
in such a simple, strict parametric manner.103 We should note that increasing the flexibility of our 




way it would if we were directly interpreting the coefficients of a logistic regression model); the 
concern here is rather in trying to as best as possible replicate the natural history.  
 Nonetheless, we acknowledged that by including a cubic term we could in fact be too 
flexible and be introducing spurious effects. We speculated that this could be the reason behind 
the lack of a clear dose-response in our results (i.e., the reason the risk differences below the null 
were seen for the 5 µg/m3 standard but above the null for the 10 µg/m3 standard). Upon repeating 
our analyses without cubic terms and then additionally without an exposure quadratic term, 
though, we estimated that all of our interventions led to increased risk of mortality (the results of 
this model were presented above in Chapter 4). This puzzling result prompted us to again run our 
analysis, with a tweaked intervention scenario. We set all counties, regardless of their observed 
exposure, at the standard under consideration and we added a third potential standard at 15 
µg/m3 (one that was larger than the current PM2.5 standard). This analysis revealed that estimated 
life expectancy if all counties were exposed to an annual PM2.5 concentration of 15 µg/m
3 was as 
large if not larger than if all counties were exposed to a concentration of 5 µg/m3. On the basis of 
this analysis, it is our current opinion that the results observed in our aim 2 analysis are the result 
of a small handful of very populous counties that have high life expectancy despite also having 
high air pollution. These counties are unique and are unlikely to have good comparators at lower 
PM2.5 concentrations. Additionally, because our outcome model considers the number who died 
and the number who survived, the massive populations of these counties provide the most 
information to the model, leading the lack of interpretability and lack of consistency with the 
literature that was seen in our results.  
 Despite our recognition of the issues above, we decided to present in the previous chapter 




we will leave reporting sub-group analysis results until our approach is finalized). They stand as 
testament to our original plan as well as the experimental nature of this work, and our open 
discussion of the pitfalls we ran into could help other investigators avoid the same problems 
when using our approach to estimate the effects of potential nationwide interventions on air 
pollution. However, following these further investigations into our data and models, we have 
proposed and plan to carry out several refinements to our approach prior to publication. We plan 
to, in our main analysis, exclude the most populous and most population dense counties in the 
US. While this will limit our generalizability, we believe the tradeoff with the increase to validity 
justifies this restriction. Furthermore, our preliminary findings from this altered approach have 
been promising, with point estimates that were more stable across model specifications and that 
showed a clearer concentration-response relationship. 
 
E. Public health significance 
Our approach to assessing trends in mortality for the entire US population over nearly a 
half century has much to add both to the way annual mortality is currently reported but also to 
studies that wish to examine (in a highly generalizable fashion) factors which could have 
reasonably impacted the observed trends. For instance, one could imagine examining the 
mortality risk curves before and after a major federal policy change to see whether that policy 
affected mortality, or one could investigate how mortality might have differed under a 
counterfactual policy change, as we went on to do in aim 2. Thus, whether the goal is simply to 
characterize the natural history of US mortality or use that natural history as a comparison group 
when estimating potential effects on mortality, our framework could be used to first estimate risk 




risk functions in a highly interpretable fashion, thereby deepening our understanding of US 
mortality trends. 
Moreover, we still believe, once we refine our approach so that is provides more stable 
and more valid results, that our aim 2 work has the potential to have a wide public health impact. 
Exposure to PM2.5 has been demonstrated to have an effect on mortality, and a policy framework 
is in place to limit emissions of this air pollutant with the goal of reducing ambient 
concentrations to below the set national air quality standards. Our work responds to calls to more 
directly examine the impacts of air pollution policies and provides a new example for how one 
might carry out this work. We used a widely generalizable study sample (which was made 
possible through a new data fusion of multiple large, publically available data sets), very recent 
data (particularly for the exposure), and modern quantitative methods previously not used in the 
air pollution literature. We employed the causal inference framework to precisely define our 
counterfactual contrast of interest as well as to rigorously think through the threats to our validity 
that we could (and could not) overcome. Thus, our work has the potential to provide additional, 
valuable insight on the effectiveness of potential stricter standards for PM2.5 in reducing all-cause 
and cause-specific mortality nationwide, thereby serving to inform policymakers when they next 




APPENDIX A. SUPPLEMENTAL TEXT 
 
1. Aim 1 additional results 
We provide results for 1970, 1985, 2000, and 2015 – four years that spanned the 48-year 
study period and illustrated well the main historic trends. Annual risk functions through age 100 
are presented. While static summary figures are given, we describe the results as shown in the 
corresponding animations progressing over calendar time. We further report several summary 
measures, including median (the first age at which 𝑅(𝑡) > 0.5) and average age at death 
(calculated as the area under the curve of the risk function) for all-cause mortality. For both all-
cause and cause-specific mortality, we give the risks at ages 60, 80, and 100 years alongside their 
standard errors (scaled by 10-4 for convenience of tabulation). Tables and figures are given 
below. 
All-cause mortality. The animation of the overall, unstratified risk curves (Movie S1) 
showed that, as time progressed from 1968 to 2015, there was a clear and steady improvement in 
the synthetic lifespans. The median ages at death in 1970, 1985, 2000, and 2015 were 75, 78, 80, 
and 83 years of age, respectively. Average ages at death in those years were 70.8, 74.6, 76.8, and 
78.8 years of age, respectively. As expected, medians were larger than the averages as a result of 
the left-skewed nature of time to death in human populations (i.e., a long, left tail and the bulk of 
deaths occurring at later ages). There was some evidence of flattening in the average age of death 
in the last years of the study period (Figure 6.1), and the 2015 average age at was in fact lower 
than the 2014 average (78.9 years), although the median ages were the same. See Table 6.1 for 
the risks of all-cause mortality in the overall synthetic cohorts. 
The animation of sex-specific curves (Movie S2) illustrated a similar downward trend in 




the median ages at death for women (men) were 79 (71), 81 (74), 82 (77), and 85 (80), 
respectively. The average ages at death were 74.6 (67.1), 78.02 (71.1), 79.2 (74.2), and 81.0 
(76.5), respectively. The risk functions further showed that risk of mortality in these two groups 
substantially differs as early as 20 years of age. The gap between women and men also 
decreased, particularly after the mid-1990s. Sex-specific risks are provided in Table 6.1.  
When stratifying by race, we saw that the median ages at death for Black Americans were 
substantially lower than for White Americans but that those listed as other race (a small but 
highly heterogeneous racial group) had the highest median ages at death. In 1970 the median 
ages were 68 for Black Americans, 75 for White Americans, and 79 for those of other race. 
Those medians were 72, 78, and 84 in 1985; 75, 80, and 86 in 2000; and 80, 83, and 89 in 2015 
(Table 6.2). The risk function animation (Movie S3) further highlighted the markedly different 
shape of the lifespan between races. White Americans and those of other race had a very similar 
lifespan through ages 40-50, but White Americans afterwards experienced higher risks of 
mortality. Black Americans experienced higher risks of mortality at younger ages than either of 
the other racial categories, but, starting in the mid-1990s, their risk function began to move 
toward that seen in White Americans. These trends largely persisted when we looked at the 
curves by both race and sex (Movie S4).  However, we did see that the curve for Black women 
began to draw closer to that for White women beginning in the late 1980s, while among Black 
men that trend began to occur in the late 1990s. 
Little difference in all-cause mortality experience was seen when we stratified by US 
Census region (either alone or jointly with sex), with the exception that in some years the South 




Cause-specific mortality. We visualized the overall cause-specific mortality results in two 
ways. First, in Movie S5A, we provide the risk functions for cardiovascular, respiratory, and all 
other causes of death. This animation revealed that, until the late 1980s, the cause with the 
greatest risk at age 100 was by far cardiovascular mortality (1970: 0.55; 1985: 0.49), although its 
curve was similar to respiratory mortality until age 40 and its risk was lower than other causes of 
death until age 80. After the late 1980s, though, the curve for other causes of death began to have 
the greatest risk at age 100 (2000: 0.48; 2015: 0.56). We can also see that there was a slight 
increase in risk of respiratory mortality at age 100 over the course of the study period (1970: 
0.06, 2015: 0.10). Second, in Movie S5B, we give these cause-specific risk functions stacked, to 
reinforce that the three risks sum to the risk of all-cause mortality. This figure further allows us 
to easily visualize what proportion of all-cause mortality was being contributed by each cause 
across the synthetic lifespan. The risks at age 60, 80, and 100 for each cause are given in Table 
6.3. 
 Upon stratification by sex (Movies S7A and S7B; Table 6.3), we observed that the above 
described relationship in the overall curves between cardiovascular mortality and the other two 
causes of death was more dramatic in women than in men. In the first half of the study period, 
women had a more pronounced gap between risk of cardiovascular mortality at age 100 and risk 
of other causes of death. For example, in 1985, the risk of cardiovascular mortality by age 100 in 
women was 0.52 while the risk of other causes of death was 0.39; in men those same risks were 
0.46 and 0.45, respectively. These results also showed that men experienced the switch between 
which cause had the greatest risk at age 100 earlier than women (1986 in men compared to 1997 




that the differences between the male and female cause-specific risk functions decreased toward 
the end of the study period. 
Stratification by race (Movies S8A and S8B; Table 6.4) revealed that the trend in 
cardiovascular mortality discussed above was seen predominately in White Americans. Among 
Black Americans and those of other races, the difference between risk at age 100 of 
cardiovascular mortality and other causes of death was small or nonexistent even as early as 
1970 (White: 0.56 vs 0.38; Black: 0.48 vs 0.45; Other: 0.46 vs 0.43). We also saw that it took 
until the mid-2000s for the proportion of deaths at age 100 from cardiovascular causes to fall 
below that of other causes of death among those of other races. Furthermore, while the lifespan 
of White and Black Americans became more similar after 2000, the curves for Americans of 
other races remained quite different from White or Black Americans. 
Results of Supplementary Analyses. After collapsing across all 48 years under study, the 
median and average ages at death from any cause were 79 and 75.6, respectively. In the first full 
decade observed (1970-79), the median and average ages were 76 and 72.3, respectively. In the 
subsequent decades, those ages were 78 and 74.5 (1980-89), 79 and 76.0 (1990-99), and 81 and 
77.6 (2000-10). These values were similar to those found at the mid-point year for each decade. 
For the full results of these analyses as well as the quinquennial results, see Table 6.5. 
 To examine the risk functions stratified by Hispanic ethnicity, we restricted the years 
under study to the post-1999 period. We found that the median (average) age at death from any 
cause in those who were Hispanic or Latino was 84 (79.7) in 2000 and 87 (82.3) in 2015. Among 
those who were not Hispanic or Latino, those ages were 80 (76.3) in 2000 and 82 (77.9) in 2015. 
We then stratified by both race and ethnicity. This further stratification revealed that those with 




median: 93), followed by those with Hispanic ethnicity and other race (2000 median: 88; 2015 
median: 91) and by Hispanic White Americans (2000 median: 83; 2015 median: 86). Then, while 
those who were not Hispanic or Latino and of White or other race had lower median ages at 
death than their Hispanic counterparts, those with the shortest expected synthetic lifespan were 
non-Hispanic Black Americans (2000 median: 75; 2015 median: 79). It should be noted, though, 
that both those who reported Hispanic ethnicity and either Black or other race comprised a very 
small proportion of the US population (each <1%). For these results, see Table 6.6. 
 The risk function animations for our more detailed cause of death outcome are given in 
Movies S9A and S9B. These animations further revealed a few causes which seem to be driving 
the trends seen in Movies S6A and S6B. For example, we saw that (unsurprisingly) the majority 
of cardiovascular deaths were deaths due to heart disease but that the proportion of all-cause 
mortality contributed by heart disease greatly decreased over the study period. In 1968 risk of 
heart disease mortality by age 100 alone was nearly equal to risk due to all other causes; 
however, by 2015 its risk function was similar to that seen for deaths due to cardiovascular 
causes other than heart disease and stroke. We further saw that strokes made up a larger 
proportion of total deaths in the first half of the study period than they did in the second half. The 
split of respiratory mortality into chronic lower respiratory diseases versus all other respiratory 
causes revealed that the small increases seen in risk of respiratory mortality by age 100, 
especially in the last decade of our analysis, were likely driven by an increase in deaths due to 
chronic lower respiratory diseases. 
 Lastly, application of compatibility ratios to the number of deaths attributed to each cause 
for those years using ICD-8 and ICD-9 coding resulted in only minor changes to the estimated 




any risk). Trends overall remained the same. Risk results from 1970 and 1985 before and after 
the compatibility ratios were applied are compared in Table 6.7. 
 
2. Further details on our implementation of Bayesian Maximum Entropy 
Exploratory analyses. 
We first conducted an exploratory analysis of the exposure, examining yearly maps of the 
data, concentration histograms, and summary statistics. We observed that, while small minimum 
(near 0 µg/m3 in some years) and large maximum (as much as 59 µg/m3) average PM2.5 
concentrations were recorded in every year, the means and medians consistently dropped from 
2000 to 2015. This downward trend is apparent in Figure 1.1, which plots the median, 25th 
percentile, and 75th percentile of annual average PM2.5 by year. Additionally, for some years, like 
2015, the histograms showed distributions of average PM2.5 that were right skewed due to a few, 
large outliers, with the bulk of measurements falling below 20 µg/m3. Two example histograms, 
for 2000 and 2015, are provided in Figure 6.2. Based on this observation, we decided to log 
transform PM2.5 before conducting BME estimation, such that 𝑍(𝒑) = log⁡(𝑌(𝒑)).  
We then plotted the spatial distribution of the average PM2.5 values at each monitor in the 
continental US for each year. The color bar was given an upper bound of 20 µg/m3 to reflect the 
pattern seen in the histograms. The maps for 2000 and 2015 are provided in Figure 1.2. The 
figures illustrated that, in general, concentrations of PM2.5 decreased over the period 2000-2015, 
although large concentrations could still be seen in the western US in 2015. There also appeared 
to be spatial autocorrelation, particularly in the large grouping of similar concentrations observed 






Prior to modelling the exposure, we also wished to select a global offset, such that we 
would complete BME estimation in the log-transformed, offset-removed field 𝑋(𝒑) = 𝑍(𝒑) −
𝑔𝑜(𝒑), where 𝑔𝑜(𝒑) is the global offset function. Two potential offsets were considered: (1) a 
flat offset and (2) a regional offset. Both offsets were the linear combination of the exponentially 
smoothed spatial mean trend and temporal mean trend; they simply differed on the level of 
smoothing, as governed by the specified radius for the time neighborhood (𝑑𝑡), radius for the 
space neighborhood (𝑑𝑠) temporal range (𝑇𝑟𝑎𝑛𝑔𝑒), and spatial range (𝑆𝑟𝑎𝑛𝑔𝑒). The formulas used 
to calculate those mean trends were described in Chapter III: 
The estimated temporal mean trends are shown in Figure 6.3 alongside the raw mean 
trend (i.e., each year’s arithmetic average across all sites), and the spatial mean trends are shown 
in Figure 6.4. In these figures, the markers are the raw mean at each monitoring site. The offsets 
were compared based upon the estimated variance, covariance model, and mean square error 
(MSE) from a BME cross-validation.  
 First, we examined using the flat offset, choosing very large radii and ranges such that the 
mean trend would be flat across the whole range of the data (10,000 for each parameter). We 
estimated the experimental covariance in the log-transformed, offset-removed data, as shown in 
Figure 6.5, and specified the following nested exponential covariance model: 













where 𝑟 is the spatial lag (in degrees) between points 𝒑 and 𝒑′ and 𝜏 is the temporal lag (in 
years) between the points. Then, treating all of the data as hard and using the above covariance 




estimating its value, and comparing the estimate to the observed value) to assess the performance 
of this approach. The MSE was 0.0647. 
 Second, we examined using a regional offset. The specified spatial radius was 90 degrees, 
and the spatial range was 0.50 degrees. The specified temporal radius was 20 years, and the 
temporal range was 3 years. We estimated the experimental covariance in the log-transformed, 
offset-removed data, as shown in Figure 6.6. We chose the following nested exponential 
covariance model: 













Treating all of the data as hard and using the above covariance model, we conducted a BME 
cross-validation to assess the performance of this offset approach. The estimated MSE was 
0.0548. 
 For both the flat and regional offset approaches, the selected covariance models 
accounted for two important types of variation in PM2.5 across the US. They have one component 
representing variation over short distances but long time periods and another component 
representing variation over larger distances but shorter time periods. A comparison of Figures 
6.5 and 6.6 shows that the approach using a regional offset had a spatial covariance that was 
more “nugget” than the flat offset approach. However, the regional offset resulted in a lower 
estimated variance and cross-validation MSE. The regional offset also better showed the 
decreasing trend in PM2.5 concentrations over time. Based on these last three factors, we decided 







Soft data approach. 
We additionally examined using two different ways to input the observed data. All of the 
above analyses treated the PM2.5 annual averages as hard (i.e., exactly correct) data. We also 
wished to assess whether treating the data as soft, probabilistic data could improve our model. 
Our soft data approach was based on the fact that very few of the EPA monitors recorded a daily 
average every day of the year; thus, the recorded annual average has a level uncertainty that is 
inversely related to the number of observations in a year. Other interpolation studies have used 
this soft data approach.29,43 In practice, this meant that we treated the annual average from any 
monitor that recorded measurements at least every 3 days as hard data (number of observations 
in the year ≥122). This cut-point was chosen because it reflects the federal reference method for 
PM2.5. Otherwise, the data was treated as soft. This soft data was input into the BME model as 









where 𝑛𝑖𝑡 is the number of observations in a year and 𝑠𝑖𝑡 is the arithmetic standard deviation 
recorded in the data. The soft data approach, like the hard data approach, used the covariance 
model from the regional global offset removed data. To compare these models, we again 
conducted cross-validation as above, but we also conducted an asymptotic cross-validation. We 
attempted to make the two models as similar as possible before conducting the comparisons; for 
instance, we specified that the maximum number of data points allowed in the estimation 
neighborhood was 3 for both hard and soft data. After these changes, the leave-one-out cross-
validation MSE for the hard data model was 0.0523. The MSE for the soft data model was 




obtain this value). When predicting the observed annual average concentrations, both models had 
similar performance, with the hard data model being slightly more accurate. In the asymptotic 
cross-validation, we used the estimated moments from the above and, in percentile increments, 
removed those observations that had the fewest number of observations in the year. We then 
recalculated the MSE in these smaller samples. The results for this cross-validation is shown in 
Table 6.7. We observed that, as records with few yearly measurements were removed, the soft 
data model began to perform better than the hard data model. This was already observed when 
only the bottom 10% in number of measurements was excluded. Based on these results, we 
decided to use the soft data model for the rest of the analysis. 
 
Exposure modeling. 
 The exposure modeling was then carried out as described in Chapter III. See Figure 6.7 









APPENDIX B. SUPPLEMENTAL TABLES 
 
 
Table 6.1 Median and average age at death and age-specific risks of all-cause mortality in select years, 





Age 60 Age 80 Age 100 
Risk SE/10-4 Risk SE/10-4 Risk SE/10-4 
1970 
Overall 100.00 75 70.78 0.21 10.07 0.67 14.30 1.00 0.43 
Men 48.69 71 67.14 0.27 12.16 0.77 10.49 1.00 0.19 
Women 51.31 79 74.62 0.15 8.29 0.56 17.30 1.00 0.67 
1985 
Overall 100.00 78 74.59 0.16 7.96 0.57 12.43 0.99 0.52 
Men 48.65 74 71.10 0.20 9.93 0.68 10.47 1.00 0.24 
Women 51.35 81 78.02 0.11 8.36 0.47 16.05 0.99 0.72 
2000 
Overall 100.00 80 76.78 0.13 6.79 0.51 7.29 0.99 0.30 
Men 49.06 77 74.22 0.16 8.27 0.59 6.91 1.00 0.20 
Women 50.94 82 79.24 0.10 7.17 0.44 13.45 0.99 0.91 
2015 
Overall 100.00 83 78.76 0.12 11.41 0.44 22.72 0.99 1.30 
Men 49.23 80 76.53 0.14 14.55 0.51 25.19 0.99 1.19 
Women 50.77 85 80.97 0.09 9.18 0.38 21.14 0.98 1.39 
Abbreviations: US, United States; SE/10-4: standard error divided by 1x10-4 











Table 6.2 Median and average age at death and age-specific risks of all-cause mortality in select years, stratified by 
race and sex 




Age 60 Age 80 Age 100 





White 87.61 75 70.78 0.21 21.81 0.67 34.67 1.00 2.02 
Black 11.13 71 67.14 0.27 10.14 0.77 14.67 1.00 0.37 
Other 1.26 79 74.62 0.15 20.09 0.56 89.57 1.00 12.63 
1985 
White 84.90 78 74.59 0.16 12.91 0.57 31.97 0.99 2.07 
Black 12.02 74 71.10 0.20 7.94 0.68 11.79 1.00 0.42 
Other 3.08 81 78.02 0.11 7.88 0.47 50.18 0.99 6.73 
2000 
White 81.76 80 76.78 0.13 9.75 0.51 20.44 0.99 1.26 
Black 13.00 77 74.22 0.16 6.96 0.59 9.02 1.00 0.45 
Other 5.24 82 79.24 0.10 5.94 0.44 37.63 0.99 5.51 
2015 
White 78.36 83 78.76 0.12 10.41 0.44 33.44 0.99 3.47 
Black 13.96 80 76.53 0.14 11.83 0.51 22.88 0.99 1.23 




White 44.85 75 70.78 0.21 19.00 0.67 41.64 1.00 3.14 
Black 5.83 71 67.14 0.27 9.07 0.77 19.24 1.00 0.65 
Other 0.63 79 74.62 0.15 15.92 0.56 87.25 1.00 15.59 
1985 
White 43.45 78 74.59 0.16 9.86 0.57 37.34 0.99 3.18 
Black 6.34 74 71.10 0.20 8.72 0.68 16.86 1.00 0.76 
Other 1.57 81 78.02 0.11 5.29 0.47 37.61 0.99 6.97 
2000 
White 41.45 80 76.78 0.13 6.71 0.51 17.95 0.99 1.41 
Black 6.82 77 74.22 0.16 7.78 0.59 16.53 1.00 1.18 
Other 2.68 82 79.24 0.10 6.01 0.44 44.66 0.99 8.02 
2015 
White 39.54 83 78.76 0.12 7.38 0.44 31.24 0.99 3.66 
Black 7.26 80 76.53 0.14 9.64 0.51 21.93 0.99 1.48 




White 42.76 75 70.78 0.21 26.28 0.67 26.96 1.00 1.01 








Other 0.63 79 74.62 0.15 26.32 0.56 93.68 1.00 10.49 
1985 
White 41.45 78 74.59 0.16 17.17 0.57 24.31 0.99 0.87 
Black 5.68 74 71.10 0.20 9.69 0.68 10.04 1.00 0.19 
Other 1.51 81 78.02 0.11 11.50 0.47 54.23 0.99 4.80 
2000 
White 40.31 80 76.78 0.13 13.79 0.51 18.36 0.99 0.64 
Black 6.19 77 74.22 0.16 8.11 0.59 8.26 1.00 0.28 
Other 2.56 82 79.24 0.10 6.31 0.44 25.47 0.99 2.71 
2015 
White 38.82 83 78.76 0.12 14.89 0.44 34.27 0.99 2.65 
Black 6.69 80 76.53 0.14 14.94 0.51 25.63 0.99 1.15 
Other 3.71 85 80.97 0.09 7.10 0.38 50.52 0.98 8.97 
Abbreviations: US, United States; SE/10-4: standard error divided by 1x10-4 





Table 6.3 Age-specific risks of cause-specific mortality in select years, overall and by sex 
Analysis Year Cause 
Age 60 Age 80 Age 100 




Cardiovascular 0.08 0.58 0.31 1.35 0.55 2.09 
Respiratory 0.01 0.31 0.04 0.52 0.06 0.73 
Other 0.13 0.97 0.32 1.43 0.39 1.71 
1985 
Cardiovascular 0.06 40.8 0.23 1.08 0.49 1.83 
Respiratory 0.01 0.19 0.04 0.47 0.08 0.80 
Other 0.10 0.78 0.30 1.26 0.42 1.65 
2000 
Cardiovascular 0.04 0.34 0.17 0.85 0.41 1.53 
Respiratory 0.01 0.15 0.05 0.46 0.10 0.78 
Other 0.09 0.67 0.30 1.17 0.48 1.62 
2015 
Cardiovascular 0.02 0.24 0.12 0.64 0.32 1.28 
Respiratory 0.01 0.13 0.04 0.40 0.10 0.73 
Other 0.09 0.60 0.28 1.03 0.56 1.63 
Women 
1970 
Cardiovascular 0.05 0.68 0.27 1.81 0.59 3.28 
Respiratory 0.01 0.39 0.03 0.62 0.05 1.02 
Other 0.10 1.24 0.27 1.89 0.36 2.44 
1985 
Cardiovascular 0.04 0.58 0.19 1.37 0.52 2.67 
Respiratory 0.01 0.24 0.03 0.57 0.07 1.07 
Other 0.07 0.99 0.25 1.63 0.39 2.26 
2000 
Cardiovascular 0.03 0.42 0.14 1.07 0.43 2.10 
Respiratory 0.01 0.20 0.04 0.61 0.10 1.04 
Other 0.07 0.86 0.26 1.53 0.46 2.19 
2015 
Cardiovascular 0.02 0.29 0.09 0.81 0.32 1.76 
Respiratory 0.00 0.17 0.04 0.55 0.10 1.00 
Other 0.07 0.77 0.24 1.35 0.55 2.24 
Men 
1970 
Cardiovascular 0.10 0.94 0.36 1.99 0.52 2.66 
Respiratory 0.01 0.47 0.05 0.83 0.07 1.05 
Other 0.16 1.49 0.36 2.13 0.41 2.40 
1985 
Cardiovascular 0.07 0.76 0.28 1.72 0.46 2.53 
Respiratory 0.01 0.31 0.05 0.77 0.09 1.22 
Other 0.13 1.21 0.35 1.95 0.45 2.43 
2000 
Cardiovascular 0.05 0.53 0.20 1.37 0.40 2.27 
Respiratory 0.01 0.24 0.05 0.70 0.10 1.22 
Other 0.11 1.02 0.34 1.80 0.50 2.45 
2015 
Cardiovascular 0.03 0.39 0.14 1.01 0.32 1.89 
Respiratory 0.01 0.19 0.04 0.59 0.10 1.10 
Other 0.11 0.91 0.32 1.55 0.56 2.39 
Abbreviations: US, United States; SE/10-4: standard error divided by 1x10-4 







Table 6.4 Age-specific risks of cause-specific mortality in select years, stratified by race 
Race Year Cause 
Age 60 Age 80 Age 100 
Risk SE/10-4 Risk SE/10-4 Risk SE/10-4 
Black 
1970 
Cardiovascular 0.10 2.11 0.33 4.22 0.48 5.98 
Respiratory 0.02 1.24 0.04 1.70 0.06 2.15 
Other 0.22 3.54 0.39 4.71 0.45 5.50 
1985 
Cardiovascular 0.07 1.68 0.28 3.59 0.45 5.27 
Respiratory 0.01 0.71 0.04 1.39 0.06 2.02 
Other 0.17 2.84 0.38 4.27 0.48 5.30 
2000 
Cardiovascular 0.06 1.24 0.22 3.01 0.40 4.58 
Respiratory 0.01 0.53 0.04 1.30 0.07 1.96 
Other 0.15 2.36 0.37 3.95 0.52 5.07 
2015 
Cardiovascular 0.04 0.83 0.16 2.22 0.34 4.07 
Respiratory 0.01 0.42 0.04 1.09 0.07 1.92 
Other 0.12 1.84 0.33 3.21 0.57 5.06 
White 
1970 
Cardiovascular 0.08 0.61 0.31 1.43 0.56 2.23 
Respiratory 0.01 0.30 0.04 0.54 0.06 0.78 
Other 0.12 1.00 0.31 1.50 0.38 1.80 
1985 
Cardiovascular 0.06 0.51 0.23 1.15 0.50 1.96 
Respiratory 0.01 0.19 0.04 0.51 0.09 0.86 
Other 0.09 0.81 0.29 1.33 0.41 1.74 
2000 
Cardiovascular 0.04 0.36 0.16 0.90 0.41 1.64 
Respiratory 0.01 0.16 0.05 0.50 0.10 0.84 
Other 0.08 0.71 0.29 1.25 0.47 1.73 
2015 
Cardiovascular 0.02 0.27 0.11 0.69 0.32 1.37 
Respiratory 0.01 0.14 0.05 0.45 0.11 0.80 
Other 0.09 0.66 0.28 1.12 0.56 1.76 
Other 
1970 
Cardiovascular 0.04 4.51 0.22 13.33 0.46 26.54 
Respiratory 0.01 2.74 0.04 5.68 0.08 11.84 
Other 0.13 8.45 0.30 14.45 0.43 22.59 
1985 
Cardiovascular 0.02 1.96 0.16 7.79 0.45 21.51 
Respiratory 0.00 0.91 0.03 3.44 0.10 10.83 
Other 0.07 3.81 0.23 8.53 0.42 18.61 
2000 
Cardiovascular 0.01 1.11 0.09 4.59 0.34 13.60 
Respiratory 0.00 0.50 0.03 2.21 0.10 6.99 
Other 0.05 2.35 0.21 5.53 0.43 12.46 
2015 
Cardiovascular 0.01 0.75 0.09 2.42 0.35 7.62 
Respiratory 0.00 0.32 0.02 1.30 0.10 4.24 
Other 0.05 1.66 0.18 3.57 0.51 8.79 
Abbreviations: US, United States; SE/10-4: standard error divided by 1x10-4 









Table 6.5 Median and average age of death and age-specific risks of all-cause mortality in a few example 
years, across different time aggregations 
Analysis Years Median Average 
Age 60 Age 80 Age 100 
Risk SE/10-4 Risk SE/10-4 Risk SE/10-4 
All Years 1968-2016 79 75.64 0.15 7.34 0.54 11.76 0.99 0.61 
Decades 
1970-79 76 72.25 0.19 9.60 0.63 17.05 1.00 0.69 
1980-89 78 74.53 0.16 7.99 0.57 12.50 0.99 0.57 
1990-99 79 75.96 0.14 9.00 0.53 8.55 0.99 0.37 
2000-10 81 77.55 0.12 6.95 0.48 10.21 0.99 0.41 
Quinquennia 
1970-74 75 71.30 0.21 10.03 0.65 15.09 1.00 0.48 
1975-79 77 73.20 0.18 9.42 0.60 18.29 1.00 0.88 
1980-84 78 74.27 0.16 8.19 0.58 14.19 0.99 0.71 
1985-89 78 74.78 0.16 8.52 0.57 11.62 0.99 0.47 
1990-94 79 75.54 0.15 9.81 0.54 10.89 0.99 0.54 
1995-99 80 76.37 0.14 8.15 0.52 6.88 0.99 0.25 
2000-04 80 77.08 0.13 6.59 0.50 8.00 0.99 0.34 
2005-09 82 78.01 0.12 8.08 0.47 14.19 0.99 0.69 
2010-14 83 78.77 0.11 10.25 0.44 21.13 0.99 1.20 
Abbreviations: US, United States; SE/10-4, standard error divided by 1x10-4 










Table 6.6 Median and average age of death and age-specific risks of all-cause mortality in a few example years, stratified by 
race and Hispanic ethnicity 




Age 60 Age 80 Age 100 
Risk SE/10-4 Risk SE/10-4 Risk SE/10-4 
All 
2000 
Hispanic 12.55 84 79.65 0.10 6.11 0.42 24.76 0.99 2.82 
Non-Hispanic 87.45 80 76.33 0.13 7.08 0.52 7.90 0.99 0.35 
2015 
Hispanic 17.61 87 82.33 0.08 6.58 0.34 51.53 0.98 8.60 
Non-Hispanic 82.39 82 77.93 0.13 12.68 0.46 23.31 0.99 1.18 
Black 
2000 
Hispanic 0.53 92 88.58 0.04 12.74 0.16 134.02 0.94 43.49 
Non-Hispanic 12.47 75 71.64 0.22 9.94 0.64 19.79 1.00 1.19 
2015 
Hispanic 0.96 93 90.76 0.03 11.27 0.10 128.22 0.92 51.38 
Non-Hispanic 13.00 79 75.37 0.17 10.78 0.53 32.22 0.99 3.18 
White 
2000 
Hispanic 11.64 83 79.31 0.11 6.20 0.43 21.76 0.99 2.35 
Non-Hispanic 70.12 80 77.24 0.12 6.99 0.51 9.34 0.99 0.48 
2015 
Hispanic 15.75 86 81.84 0.09 6.80 0.35 48.20 0.98 7.57 
Non-Hispanic 62.61 82 78.55 0.12 12.51 0.45 23.37 0.99 1.23 
Other 
2000 
Hispanic 0.37 88 83.57 0.07 11.11 0.31 80.30 0.97 15.29 
Non-Hispanic 4.87 78 74.18 0.15 12.86 0.59 23.46 1.00 0.73 
2015 
Hispanic 0.89 91 87.53 0.05 9.66 0.18 104.37 0.94 31.23 
Non-Hispanic 6.78 80 76.73 0.13 15.38 0.50 33.42 0.99 1.61 
Abbreviations: US, United States; SE/10-4, standard error divided by 1x10-4 









Table 6.7. Soft data model and hard data model 
MSEs, after records with yearly number of 
measurements below the percentile cut-point 
were removed  
Percentile cut-
point 
Hard data only 
MSE 
Soft and hard 
data MSE 
0.1 0.0553 0.0538 
0.2 0.0562 0.0376 
0.3 0.0589 0.0355 
0.4 0.0458 0.0373 
0.5 0.0492 0.0385 
0.6 0.0538 0.0304 
0.7 0.0575 0.0306 
0.8 0.0514 0.0320 







APPENDIX C. SUPPLEMENTAL FIGURES 
 
 
Figure 6.1 Trends in the median and average age at death due to any cause in the overall 





















Figure 6.3. Estimated raw, flat, and regional temporal mean trends of log(PM2.5), 2000-










Figure 6.4. Flat and regional spatial mean trends for log(PM2.5), with circles showing raw 










Figure 6.5. Estimated spatial and temporal covariances with covariance models for 𝑿(𝒑) 











Figure 6.6. Estimated spatial and temporal covariances with covariance models for 𝑿(𝒑) 
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